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Abstract 
SYNTHESIS OF CYCLEN BASED RECEPTORS FOR PYRENE 
DYES AND THEIR USE IN SEPARATIONS BIOTECHNOLOGY 
By Vivek Kaushik, Ph.D. 
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2011 
 
Major Director: Vladimir A Sidorov, Ph.D. 
Associate Professor Department of Chemistry 
 
  A number of purification techniques such as adsorption, centrifugation, chromatography, 
extraction, distillation, filtration, precipitation etc. to name a few, are commonly used for 
the purification. However, due to a constant need of purification of even more complex 
crude mixtures, be it reaction mixtures, various proteins and DNA from cell extracts or 
medicinal compounds and fragrances from plant extracts, scientists needed to consistently 
develop new and improved techniques of purification. One such great advancement in the 
field of chromatography was the development of affinity chromatography. It revolutionized 
the field of bioseparations technology, and the dream of single stage purification of 
complex biological substrates such as proteins, enzymes, co-enzymes, DNA, RNA etc. was 
realized. 
Development of various precipitation techniques involving phase tags, acid-base induced 
precipitation, host-guest interactions, chemoselective precipitation etc. further simplified 
xiv 
 
 
 
purification procedures for few substrates. However, only a few examples of chemoselective 
precipitation are known in literature.1
,
 2  
In 2005, our group synthesized a cyclen-based receptor.9 This receptor showed very strong 
and very specific affinity for the pyrene based dyes (HPTS, APTS, PTA) under physiological 
conditions, similar to that of the natural receptors for their ligands. Upon interaction with the 
dye, this artificial receptor formed a low solubility complex which had micromolar stability.  
Various structure and activity studies established the essentiality of the macrocyclic structure 
of the receptor for the dye recognition. We further decided to study the effect of various 
substituents on the aromatic ring on the binding and quenching affinity of the receptor. A 
series of receptors bearing electron-withdrawing and electron-donating substituents were 
synthesized (receptor 4-6). We also synthesized a receptor having aliphatic groups instead of 
aromatic groups attached to the thiourea group (receptor 7) as well as a receptor lacking 
thiourea linkage (receptor 8). The results of fluorometric titrations of these receptors were 
consistent with the previous structure and activity studies, as the receptors having electron 
withdrawing  nitro- and bromo substituents (receptor 4 and 6 respectively)  on the aromatic 
groups (have increased π-stacking) were better receptor than cyclen 1. Interestingly, the 
receptor 5, bearing an electron-donating methoxy groups on the aromatic ring, has also 
shown an increase in the affinity towards HPTS. We speculated that this increased affinity 
could be due to the higher affinity of receptor 5 towards Na
+
 which was essential for the 
proper arrangement of the receptor binding arms. The receptor with the aliphatic chain 
(receptor 7) showed a complicated complexation process and showed variable fluorescence 
quenching at various receptor concentrations. This behaviour was probably due to the 
formation of complexes of a various stochiometries. Expectedly, the receptor lacking thiourea 
group (receptor 8) did not show any interaction.  
xv 
 
 
 
 
Since this receptor-dye pair formed a low solubility complex of micromolar stability upon 
interaction, we hypothesized that this receptor-dye pair can be used in the selective separation 
of substrates by chemoselective precipitation. We reasoned that if the substrate of interest can 
be attached to the dye, this dye-substrate conjugate then can be selectively precipitated from 
the reaction mixture upon addition of the receptor. We tried our concept for the separation of 
lactose from lactose/sucrose mixture. Being a reducing sugar, lactose was labeled with APTS 
dye, whereas sucrose that lacks the reducing end, remained unmodified. Application of the 
cyclen receptor to this mixture resulted in precipitation of APTS-lactose conjugate, leaving 
sucrose as the only component in the solution.10 By coupling APTS dye with lactose via an 
imine bond, we were able to successfully isolate unmodified lactose from the conjugate by 
subsequent hydrolysis of the conjugate.10 
 
 
Figure 1. Structure of various receptors synthesized having different X and R groups 
4 
Scheme 1. Structure of a) fully reduced lactose-APTS conjugate b) partially reduced lactose-APTS conjugate. 
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Next, we decided to use this dye-receptor pair in affinity chromatography. We hypothesized 
that if the receptor can be immobilized on some solid support then it can be specifically used 
as an affinity support for the substrates which are attached to the pyrene-based dyes. A new 
receptor with a functional group on the cyclen core was needed to immobilize the receptor on 
the solid support. The receptor 11 (fig. 2.A) having an aromatic primary amine group was 
synthesized. This receptor was successfully immobilized on the NHS activated agarose resin. 
A series of fluorometric experiments were performed to determine the specificity and binding 
ability of the affinity support towards the pyrene dyes. Initial results of these experiments 
indicated that the affinity support was very effective as indicated by almost 95% fluorescence 
quench of a solution of 50 nM HPTS and affinity resin (fig. 2.B).  
 
                                                                                                                       
This work has opened several new venues of research, and the applicability of this dye-
receptor pair in the fields of biochemistry, pharmacology, cell biology etc. will be explored.
 
 
 
 
Figure 2. A) Structure of receptor 11; B) Emission spectra of 50 nM HPTS dye in the presence of the resin and 
(or) free or immobilized receptor 11. 
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Chapter 1 
Separations Technology-Affinity chromatography and chemoselective 
precipitation 
1.1 Introduction 
Since ancient times, people have used methods of separating and purifying chemical 
substances for improving the quality of life. The extraction of metals from ores and of 
medicines from plants is older than recorded history. Gold was mined as early 2
nd
 and 3
rd
 
century AD in India as proved by the gold objects found in Harappa and Mohenjo-daro. 
Fragrances were first extracted from various plants and flowers by ancient Egyptians. One 
very common and modern example which revolutionized human history is purification of 
crude oil. It is a mixture of various hydrocarbons and each has a significant use. Crude oil 
is purified by fractional distillation into individual hydrocarbons such as gasoline, diesel, 
jet fuel, lubricating oil, asphalt etc. 
Nowadays, discovery of most of the new compounds results from synthesis in the 
laboratory. Laboratory preparation of a compound often yields a crude mixture containing 
some quantities of the unreacted starting materials as also impurities that are by-products 
from side reactions. A substance that occurs in a natural source is also rarely present as a 
single entity in that source. The first demand on the chemist or the biochemist is the 
isolation of the pure compound from the crude mixture that has resulted from either the 
laboratory synthesis of the compound or its extraction from one of its natural sources. The 
chemist or the biochemist proceeds to study the properties or details of the structure of a 
compound only after it has become available in the pure state.  
 2 
 
A number of purification techniques such as adsorption, centrifugation, chromatography, 
extraction, distillation, filtration, precipitation etc. to name a few, are commonly used for 
the purification. However, due to this constant need of purification of complex crude 
mixtures like reaction mixtures, various proteins or DNA from cell extracts, scientists 
needed to develop new and improved techniques of purification. One such great 
advancement in the field of chromatography was the development of affinity 
chromatography. It revolutionized the field of bioseparations technology and as a 
consequence, the goal of single stage purification of complex biological substrates such as 
proteins, enzymes, co-enzymes, DNA, RNA etc. was realized. Development of various 
precipitation techniques involving phase tags, acid-base induced precipitation, host-guest 
interactions etc. further simplified purification procedures for few substrates.     
1.2 Affinity Chromatography: 
Affinity chromatography is a purification technique based on highly specific and reversible 
interactions between two molecules. Interactions between antibody and antigen, protein and 
metal-ion, enzyme and substrate, dye and protein etc. are few very common examples of such 
interactions which formed the bases of affinity chromatographic separation of these 
substrates from the complex mixtures. 
                 
Scheme 1.1. A schematic representation of various affinity chromatography steps.
85 
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1.2.1 Immunoaffinity Chromatography (IAC) 
The concept of immunoaffinity chromatography goes back as early as 1924 when Engelgardt 
suggested "the method of fixed partner" and used immobilized antibodies to catch free 
antigen in fluids.11 In early 1950s Campbell et al. successfully isolated antibodies with 
antigens immobilized on azide-activated cellulose.12 Even though, the idea of immunoaffinity 
chromatography originated in early twentieth century, it took several decades to expand the 
use of the method for the separation of different types of antigen and antibody fragments.13-15 
Discovery of monoclonal antibodies in 1970s greatly accelerated development of IAC.16  
IAC is a separation method based on specific and reversible interaction between an antigen 
(Ag) and a matrix bound antibody (Ab), and is capable of effecting high yield single stage 
purification of many biomolecules.11 IAC can be used in the separation of various 
biomolecules such as proteins of pharmaceutical interest,17-20 vaccines, small biomolecules21 
and virtually anything for which monocolonal antibody (MAb) can be made. Separation by 
IAC involves a number of steps. First is to find an ideal support, followed by activation and 
immobilization of affinity ligand on the support. This support is then loaded with the crude 
extract having desired product and finally eluted to separate the desired product from other 
impurities. 
Matrix: 
The matrix is the solid support on which antibodies are immobilized for IAC. An ideal 
immunoadsorbent should be macroporous, stable, highly functionalized, easy to activate, 
hydrophilic and inert.22-24 
The most popular support matrix for affinity chromatography is beaded agarose. The 
favorable characteristics of agarose include its high porosity, hydrophilicity, chemical 
 4 
 
stability, and its relative inertness towards nonspecific adsorption.25 However, agrose is not 
very stable.26 This problem was overcome by cross linking agarose with epichlorohydrin.26 A 
major disadvantage of beaded agarose is its inability to withstand high pressure gradients, 
even when cross linked.  
Another popular support is polyacrylamide porous beads. These are prepared by the 
copolymerization of acrylamide and N-N
’
methylene-bis-acrylamide. Polyacrylamide gels are 
hydrophilic, free of fixed charge, stable in aqueous environment between pH 2-10, and 
tolerate dilute organic acids.26 A major disadvantage is microporosity which hinders the 
efficient immobilization of Ab.16 
Poly(HEMA), a copolymer of hydroxyl methacrylate and ethylene glycol dimethacrylate;  
azalactone functional copolymer beads, made by copolymerization of azlactone functional 
vinyl monomers with acrylamides or acrylates; and cellulose are other supports used in 
affinity chromatography. 
Silica is the inorganic support used in IAC. However, pure silica, due to irreversible 
adsorption and denaturation of many biomolecules, has limited use in immunoaffinity 
chromatography.16 Synthesis of modified silica, covered with a hydrophilic surface layer, 
made it more compatible for IAC. High stability and its ability to withstand high pressure 
have made silica an ideal support for high performance immunoaffinity chromatography 
(HPIAC).27  
Activation and Coupling: 
All the matrices discussed above are highly functionalized; however, not all of them are 
reactive enough for the immobilization of the Ab on the matrix. Hence, these functional 
groups need to be activated in order to attach Ab to the solid support. Several activation 
 5 
 
strategies have been successfully used to activate the solid support. These methods fall under 
two basic categories: 1) those that produce randomly oriented immobilized Abs 2) those that 
produce more uniformly oriented Abs. Proper orientation of Ab is necessary for effective 
binding to the Ag. Antibodies have Y shaped structure with antigen binding region (Fab 
region) located in the tip of arms. The base of the Y is called Fc region (fig. 1.1).28 
  
 
Abs immobilized using Fc region retain full activity and bind with the Ag. However, Abs 
immobilized on the solid support using Fab region, loses partial or complete ability to bind 
the Ag depending on whether one or both the Fab regions of the Ab are used for 
immobilization (fig. 1.2).29 
Figure 1.1. Structure of antibody showing Fab and Fc regions and mechanism of recognition of antigen by 
antibody.
190
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Cyanogen bromide (CNBr): It is the most popular and very effective method for the 
activation of solid supports.30, 31 One big advantage of using CNBr is its ability to activate 
most matrix surfaces under aqueous conditions. However, CNBr is volatile and toxic, hence, 
newer procedures employing cyanylating agents32 such as p-nitrophenylcyanate  (pNPC) or 1-
cyano-4-(dimethyl-amino)-pyridinium tetrafluoroborate (CDAP) have been introduced. One 
disadvantage of CNBr-activated supports with respect to Ab immobilization is the slow 
leakage of the protein over time.33 This can be attributed to the inherent instability of the 
isourea bond through which Ab is coupled to the support.32 
Sulfonyl chlorides: Tresyl chloride and tosyl chloride are the two most commonly used 
sulfonyl chlorides for the activation of solid supports.34 Tresyl chloride is preferred as it 
forms sulfonates more readily and is easily displaced at neutral pH and 4
0
C.34 
Carbonyldiimidazole: Another activation procedure for hydroxyl groups uses 1, 1’-
carbonyldiimidazole to introduce activated carbamates as the reactive species.35, 36 
Periodate oxidation: Supports containing vicinal diol groups can be activated by sodium 
metaperiodate, oxidizing the diols to aldehyde group. Amino group on the protein reacts with 
the aldehyde group under mild conditions (aqueous buffer at pH 7-8) and forms an imine 
bond which is subsequently reduced with sodium borohydride or sodium cyanoborohydride 
to produce a stable secondary amine bond. 
Figure 1.2. Idealized representation of Ab immobilized by random coupling procedure. 
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Activation by hydrazine, azalactone and N-hydroxy succinimide are some other methods 
used to activate solid supports having functional groups other than –OH group. 
 
 
Methods for oriented Ab immobilization: 
All of the above mentioned methods results in random orientation of coupled Ab, which tend 
to reduce its ability to bind Ag. Several schemes for achieving oriented coupling have been 
reported. One such scheme involves immobilization of Protein A on the solid support, which 
has strong affinity for the Fc region of many IgG subclasses.37, 38 This protein is then cross 
linked to Ab with dimethyl pimelidate. Using Protein A agarose, Sisson and Castor reported 
complete Ab attachment and full Ab activity.38 
Another approach involves oxidation of carbohydrate moiety of IgG with periodates to 
produce reactive aldehyde groups, located mostly within the hinge region of Ab molecule. 
The modified IgG is either coupled to a surface containing amines or more reactive hydrazide 
Scheme 1.2. Selected activation and coupling pathways: A) Cyanogen bromide; B) Sulfonyl chloride; C) 
Carbonyldiimidazole; D) Periodate oxidation 
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groups.39, 40 Prisyazhuoy et al., utilized the SH groups of the Fab
’
 fragment to create an 
oriented Ab fragment.41  
Loading: 
The objective of loading is to retain only the desired product on the support. Usually pre-
column clarification of the crude extract is done prior to loading in order to prevent fouling or 
clogging of the column. This solution is then introduced in the column. The flow rate of the 
crude solution is limited either by the mechanical rigidity of the support matrix or the time 
required for the diffusion of the product into the pores of column matrix. In stirred tanks, the 
matrix and crude mixture are mixed together for a fixed time, after which solid phase is 
collected.16 One variation of stirred tank methods uses magnetic affinity beads which can be 
separated from other insoluble compounds by collecting them in a magnetic field.29, 42 
Washing:                                                                                                                             
Following the loading, column is washed with physiological buffers (e.g. phosphate buffered 
saline, pH 7.2). The column is washed to remove unbound impurities present in the fluid 
volume of the column as well as those bound nonspecifically to the affinity support. 
However, one must be careful with washing as excessive washing can result in product loss. 
Thus, it may be necessary to compromise between yield and purity. 
Elution:  
In this step, product is recovered from the column by using a solvent that reduces affinity of 
Ag to Ab. A number of procedures have been described. These includes use of either high43 
or low pH,16, 44 chaotropic agents such as KSCN,45 organic solvents such as ethylene glycol,46 
DMSO,47 or acetonitrile,48 high49 or low ionic strength,50, 51 increased temperature,52 
denaturing agents11 such as 8M urea or 6M guanidine and others. Alternatively, gentler 
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elution methods that have been described include electrophoretic elution,53 pressure induced 
elution54 and metal ion elution18 in which Ag-Ab binding depends on the presence or absence 
of a metal ion.  
Regeneration and cycling: 
Since Ab and MAb are expensive, it is absolutely necessary to regenerate the immunoaffinty 
columns for further use to make it economically viable process. In this step column is washed 
with the solutions to remove elution buffers, as well as component of the crude extracts that 
have bound nonspecifically to the column and have not been released by either washing or 
elution. One protocol suggests a routine wash with 2M KCl/6M urea after each use.11 
Applications of IAC: 
The most important application of IAC is protein purification. IAC has been used both for 
laboratory scale and preparative scale purification of proteins.29 At laboratory scale cost is not 
a primary concern as the scale is small, and main focus is placed on the development of new 
purification methods for the substances that have not been previously purified. In contrast, 
the cost is the most significant factor at preparative scale purification. This requires careful 
selection of support, the coupling chemistry, the ligand and the elution and washing 
conditions such that the column capacity is retained over repeated cycles.29 Other uses 
involve use in assays and subtractive chromatography.     
1.2.2 Immobilized Metal-Ion affinity chromatography (IMAC) 
The basis of the method was first introduced by Helfferich55 in 1961 when he showed that 
metal ions immobilized on the resins can be used for the separation of the compounds which 
form complexes with them. Everson and Parker56 were the first, who adopted immobilization 
of the chelating compounds for the separation of metalloproteins. The method became 
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popular through the research work of Porath,57, 58 and Sulkowski,59-62 who laid the foundation 
of this technique, mainly on its use for the separation and isolation of proteins. 
  In IMAC, metal ions are loaded on a sorbent or matrix using multidentate chelating groups 
which are covalently attached to the matrix. Chelating groups and metal ions form 
complexes, as a result of which metal ions are secured for subsequent interaction with the 
compound to be resolved. To this end, the metal ions must have free coordination sites in 
order to allow the interaction with proteins. These interactions between metal-ions and 
proteins are extremely complex in nature and can involve electrostatic, hydrophobic and 
donor-acceptor interactions. It has been found that histidine, tryptophan and cysteine residues 
in proteins are critical for protein separation in IMAC,63 due to the strong interactions of these 
residues with the metal ions. Since there are a limited number of cysteine residues on the 
surfaces of proteins, histidine plays the role of a major target for metal ion complexation.64, 65 
Metal Ions: 
Metal ions can be divided into three categories: Hard, borderline or intermediate and soft 
ions, based on the principle of hard and soft acids and bases (HSAB) described by Pearson.66 
Fe (III), Al (III), Ca (II), Mg (II), and K (I) belongs to the hard metal ions group, which show 
preference for oxygen, aliphatic nitrogen and phosphorus. Soft metal-ions such as Cu (I), Hg 
(II), Ag (I), etc., prefer sulfur containing ligands and borderline metal-ions Cu (II), Ni (II), Zn 
(II), and Co (II) coordinate aromatic nitrogen, oxygen and sulfur.64 The most commonly used 
metal-ions are transition ones, Cu (II), Ni (II), Zn (II), Co (II), and Fe (III), especially Ni (II) 
as it  provides a coordination number of six, electrochemical stability under chromatographic 
conditions, borderline polarizability and redox stability.22 
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Chelating Ligands: 
 In IMAC metal-ions are immobilized on the matrix using chelating ligands. These are 
compounds that form complexes with metal ions and retain them on the solid support. 
Various types of multidentate ligands are commonly used for the immobilization of metal-
ions.55 The stability of metal ion complex with a chelating ligand depends upon multiplicity 
of the chelate, hence order of stability is penta> tetra> tridentate58, 64, 65 which implies a lower 
metal-ion leakage in higher dentate chelate. However, the stronger metal-chelate complex 
comes at the expense of weaker protein binding. Therefore, the order of biomolecule 
adsorption strength is tridentate> tetradentate> pentadentate.58, 65 As a result, most of the 
investigations have focused on the use of tri and tetradentate ligands which hold on the metal 
ions sufficient strength without sacrificing too much binding affinity of the metal ion to the 
proteins.   
Triazine dyes such as Cibacron blue, Cibacron red, Procion brown etc. are also used as 
chelating agents in IMAC.67-69 However, their use is very limited as they form weaker 
complex compared to multidentate chelates. Also, the dye ligands are used as affinity ligands 
themselves, which implies that part of biomolecule adsorption on this kind of immobilized 
metal affinity matrix may be through the dye affinity adsorption and not completely due to 
the metal ion interaction.68-70   
Matrix: 
For an adequate use in IMAC, the matrix must be stable, have functional groups on the 
surface that are easy to derivatize, hydrophilic, have high porosity with fairly large pore size, 
allow the use of high flow rate and provide a stable bed. Classical stationary phases are based 
on soft gel matrices, such as agarose, beaded cellulose or cross linked dextran.71, 72 However, 
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these matrices are compressible and restricted to low flow rate, hence their use on the large 
scale in industry is limited.65 
Silica is an ideal rigid support, as it can be manufactured with large pores and narrow pore 
size distribution to efficiently increase the macromolecular transfer inside the matrix.73 
However, nonspecific adsorption of proteins to silica by complex hydrophobic interactions 
and instability under basic conditions (pH>8.0) limits the use of silica in IMAC. In order to 
overcome these problems silica-based matrices are normally coated with hydrophilic 
polymers such as agarose,65, 74, 75 dextran74-77 and chitosan73, 78, 79. Not only such coatings reduce 
the nonspecific adsorption through the increased hydophilicity, but they also increase 
chemical stability and loading capacity of the coated silica.  
Activation and ligand immobilization conditions: 
While immobilizing ligand on the matrix, care should be taken that only the least critical 
regions of the ligand are used for immobilization. Reaction conditions should be chosen in 
such a way that the loss of ligand activity is minimal. Steric hindrance between the ligand and 
the protein is another major concern, as active sites of the biological molecules are often 
located deep within the three-dimensional structure of the molecule which can severely 
hinder protein binding capability of the ligand. This problem can be overcome by use of 
spacer arms between matrix and the ligand molecule. An ideal spacer arm must be 
bifunctional so that it can react with both matrix and the ligand. It should not have any active 
center to cause extra non-specific adsorption.23 
Two alternative procedures may be followed. The matrix is first activated with an activation 
agent, and then spacer arm is attached covalently to the matrix through the active points.80 
The ligand is then reacted with the other end of the spacer molecules. Alternatively, the 
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ligand-spacer arm conjugate is first synthesized and then attached to the matrix in one single 
step. 
Cyanogen bromide, activation of –OH groups to oxiran groups with bisoxiranes, 
epichlorohydrin, or epoxy bromopropane and oxidation of two vicinal cis-hydroxyl groups to 
aldehyde using sodium peroxide are few commonly used activation methods.30, 80, 81 
Loading: 
The interactions between protein and the immobilized metal ion are very complex in nature 
and vary from electrostatic interactions between charged biomolecule and (a) positively 
charged metal-ions, (b) negatively charged sites remaining on the matrix, hydrophobic 
interactions between biomolecule and the matrix surface and/or donor-acceptor interactions 
of the exposed amino acid residues with the metal-ions.23, 81-83 Various factors such as the 
nature of chelating ligand, metal ion, surface amino acid composition, nature of buffer salts, 
pH, and ionic strength of the loading buffer determine the dominant interaction over the 
others during loading. It has been found that at higher ionic strengths protein adsorption 
become more selective.84-86 The protein adsorption is controlled by the pH of the medium as 
protons affect the net charge on the immobilized metal-ions as well as the surface properties 
of the proteins resulting in an altered retention behavior.58, 84, 85, 87, 88 
Elution: 
In this step, buffer solutions of a pH value lower than the pKa of surface exposed electron 
donating amino acids or high ionic strengths are used to elute proteins from the column. If 
harsher conditions are needed, a high displacement agent e.g., imidazole or stronger metal 
chelating agent e.g., EDTA could be used.58 Some elution protocols involving the 
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simultaneous use of both imidazole addition and pH decreasing gradient in order to achieve a 
better chromatographic resolution have been described.64     
Application: 
Protein purification:  
Histidine residues are found on most of the natural proteins, but due to their mild 
hydrophobicity, only few of them are located on the protein surface.65 Also, there are steric 
concerns as well, as proper accessibility is required to form stable complex between the 
histidine residue and the metal ion chelate conjugate. 
Hochuli et al.89 showed that affinity tags attached to the C- or N-terminus of the recombinant 
proteins can be used for the purification of proteins by IMAC. Usually histidine tags of 
various lengths have been used as affinity tags. His6 having six consecutive histidine residues 
is the most commonly used affinity tag.89-96 Histidine tagging and IMAC have become a 
routine for easy first-time isolation of newly expressed proteins. 
IMAC and protein refolding: 
Inclusion bodies produced in E. coli are composed of densely packed denatured protein 
molecules. These proteins are biologically inactive and need elaborate solubilization, 
refolding and purification to yield the functionally active product. But these processes are 
highly cumbersome, result in poor recovery and account for the major cost in the production 
of recombinant proteins from E. coli.97 
Recently, a new IMAC based matrix assisted method has been developed for the production 
of soluble and functional proteins from inclusion bodies. It involves production of tagged 
proteins in inclusion bodies which are then solubilized, denatured and immobilized on a 
charged resin. These immobilized proteins are then renatured or refolded (using various 
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denaturing and renaturing procedures)98-106 on the matrix followed by elution of protein from 
the matrix in its native and soluble form. 
Other uses of IMAC involve separation and enrichment of phsphoproteins and 
phosphopeptides using Fe (III) and Ga (III) embedded matrices.107    
1.2.3 Dye-ligand affinity chromatography 
Most of the affinity chromatography techniques involve immobilization of antibodies, amino 
acids, proteins, nucleic acids, oligonucleotides, enzymes, coenzymes and cofactors on the 
solid matrix.108, 109 These ligands are expensive due to the high cost of production and/or 
extensive purification steps. Moreover, as use of harsh conditions can cause degradation of 
the ligands, it is difficult to immobilize certain ligands, as standard conditions are not 
sufficient to immobilize these ligands on the support. Also, precaution is required during the 
sorption and elution steps, as the use of harsh conditions can damage the affinity ligand. 
The dye-based ligands provide exciting alternative to the natural counterparts for the specific 
affinity chromatography. These dyes are synthetic, inexpensive, commercially available 
compounds that can be easily immobilized on the matrices bearing hydroxyl groups. Dye-
based ligands are able to bind most types of proteins, especially enzymes, in some cases in a 
remarkably specific manner. 
Chemical structures of the dye-based ligands: 
Triazinyl-based dyes are the most widely used in protein purification (fig. 1.3.a).Cyanuric 
chloride (1, 3, 5-trichloro-syn-triazine) forms the core structure of the dye. Due to the 
presence of the chlorine atoms these three carbons become highly susceptible to nucleophilic 
substitution reactions.24 Chromophore molecules are easily attached to this molecule to form 
dichlorotriazinyl dyes. The procion MX (fig. 1.3.b) series is a typical example of this type of 
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dyes.110, 111 By further reaction of these molecules with other nucleophilic substituents, 
monochlorotriazinyl dyes are synthesized. Cibacron112
,113  and Procion H110, 111, 114 are 
examples of such dyes (fig. 1.3.c). Two dichlorotriazinyl molecules can be coupled with a 
bifunctional molecule to form bifunctional triazinyl dyes. Procion H-E is an example of this 
type of dye (fig. 1.3.d).114   
 
 
The latest development in the dye-ligand affinity chromatography is the use of “biomimetic 
dyes”.115 These are synthetic dyes which mimic the structure and binding of natural biological 
ligands of the targeted protein. These dyes retain advantages of the parent dye but have 
improved specificity towards the target protein. The first biomimetic dye was prepared by 
linking benzamidine to the reactive chlorotriazine ring via the diaminomethylbenzene 
group.116 It was used for the specific separation of trypsin from the chymotrypsin.117 Isolation 
of kallikrein from a crude pancreatic extract and purification of alkaline phosphates from calf 
intestinal extract are few examples where biomimetic dyes were used for specific purification 
of the target protein.118 
 
Figure 1.3. Structure of some of reactive dye molecules. a) cynauric chloride b) Procion MX series c) Cibacron 
and Procion H d) Procion H-E 
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Matrix: 
As discussed in previous sections, an ideal matrix should be stable, have high porosity and 
fairly large bead size, have functional groups, exhibit minimal nonspecific binding to the 
biomolecules and hydrophilic. Most commonly used matrices are cross linked agarose beads, 
cellulose, sephadex, acrylamide gels and controlled pore glass.71, 72 
Ligand Immobilization: 
The choice of coupling methods and the reaction conditions depends on both the matrix and 
the ligand. The least critical regions of the dye should be used for immobilization to ensure 
minimal interference with the specific interactions between immobilized ligand and the target 
molecule. As the active sites of the biological molecules are often located deep within the 
three dimensional structure of the molecule, spacer arms are frequently placed between the 
matrix and the ligand to ensure their accessibility to the target. 
Nonreactive dyes can be coupled to the matrix by usual activation methods. Many reactive 
dyes are directly immobilized on the matrix by direct reaction between the reactive groups 
(mainly hydroxyl groups) on the matrix and the dye molecules (through chloride or fluoride 
atoms) on triazinyl groups.119-122     
Loading: 
Before loading, the column is washed with the equilibrating buffer solution, followed by 
loading of target protein on the column in a buffer solution having same pH and ionic 
strength as that of the equilibrating buffer solution. The pH and ionic strength of buffer is 
optimized for each specific case. Usually phosphate buffers are used as they reduce non 
specific protein-dye-ligand interactions. When the low conductivity buffers are required, 
MOPS, MES, HEPES or Tris buffers are often chosen. Metal ions (Mg
2+
, Ca
2+
, Zn
2+
, Fe
3+
, 
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Al
3+
etc.) may be added into the buffers to increase the affinity of the dye-ligand to the target 
protein, and/or to stabilize the protein molecules in the aqueous media. However, 
precipitation of the metal ions, which is pH dependent, may cause problems; therefore 
necessary precautions should be taken into consideration. Temperature is another factor that 
affects affinity interactions. Therefore, it should be kept constant at the optimum value both 
at the sorption and elution steps. The linear flow rate of the buffers should be optimized. 
There are two protocols that can be followed in the adsorption step. The first one is known as 
the “positive binding” method. This method involves use of an adsorbent that specifically 
binds the target protein along with few other contaminating proteins. These contaminating 
proteins are then flushed out of the column using equilibrating buffer before the elution step. 
Alternatively, a “negative binding” protocol, in which contaminating proteins are adsorbed 
on the column preferentially, can be used.123, 124 Higher target recovery and purity can be 
achieved in a two step process, in which the protein mixture is passed through a negative 
binding column, and effluent of this column is then directed to the second, positive binding 
column. 
Elution: 
The objective of elution step is to completely elute the desired protein, at the same time 
minimizing the amount of the contaminating proteins which may be co-eluted. Elution of the 
bound proteins may be achieved by nonselective or selective processes. In the nonselective 
elution, pH, ionic strength, or polarity of the elution buffer is changed to elute protein of 
interest. If the electrostatic interactions are dominant, an increase in pH may be sufficient to 
elute the bound protein molecules. If the cation exchange is important, a very sharp effect of 
ionic strength is observed on protein elution.55 If hydrophobic interactions are predominating, 
the polarity of eluting buffer can be reduced to promote elution. Chaotropic agents are highly 
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effective for protein elution.125However, chaotropes may cause significant degree of protein 
denaturation, and therefore they are not recommended to be used at elution step. Chaotropic 
solutions are effective to remove residual proteins for regeneration of dye-ligand sorbents for 
repeated use. 
In selective elution, the affinity eluants are used, which compete with the dye ligand for the 
same binding site on the adsorbed target protein. Nucleotide cofactors such as NADP
+
, 
NADH, ATP and AMP have been used to elute dehydrogenases and other nucleotide 
dependent enzymes from immobilized Cibacron blue F3GA and other reactive dyes.126                 
1.3 Chemoselective precipitation 
Only a few examples of such chemoselective precipitation are known in literature.1
,
 2 Of most 
prominent examples, precipitation of C60 with calixarenes and related macrocycles, 
developed by Atwood and coworkers, serves as a proof of efficiency of such methodology.3
,
 4 
While being efficient, Atwood’s protocol lacks versatility as it is only applicable to a specific 
pair of substrate and macrocycle, and is not applicable to biological substrates, which must be 
extracted from the aqueous medium. A precipitation methodology for isolation of non-
biological targets has been introduced by Wilcox et al..127
,
 128
,
 129 It will be discussed in detail 
in the next section. 
1.3.1 Precipitons: 
In 2001 Craig Wilcox introduced a new concept of “precipiton” assisted separation of 
product from a reaction mixture. A “precipiton” is a group of atoms (molecular fragment) 
that is purposefully attached to a reactant molecule and can be isomerized after the reaction to 
facilitate precipitation or the phase transfer of the attached product.5-7 Various studies showed 
that cis-stilbenes were more soluble than the trans-stilbenes in various organic solvents. This 
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varying solubility formed the basis for the development of the precipiton.8 The biphenyl-
derived alkenes 3Z and 3E were prepared by Wittig reaction (scheme 1.3).5 
 
 
 
 Alkene 3Z was freely soluble in common organic solvents such as EtoAc, THF, Et2O, 
CH2Cl2, CHCl3 and C6H5CH3 while 3E isomer was virtually insoluble in all those solvents. 
Before using these auxiliary groups for isolating products, various isomerization conditions 
such as photochemical methods (with or without sensitization),130 isomerization using  
diphenyl disulfide131 and isomerization using iodine with benzoyl peroxide under illumination 
by a sun lamp were examined. However, photochemical methods were not satisfactory as the 
reactions were slow and side products were generated during the course of reaction. In 
contrast, the last two methods were very effective and afforded excellent yields of 
precipitated products. 
Isolation of Isoxizolines using Precipitons: 
Scheme 1.3. Synthesis of precipiton 3Z. a) KHMDS, THF, -78
0
C, 81%; b) 1. tBuLi, THF, -78
0
C; 2. DMF, -78-0
0
C, 
97%; c) NaBH4, EtOH, 0
0
C, 98% 
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 Isoxazolines are a class of compounds synthesized by [3+2] cycloaddition reaction between 
alkenes and nitrile oxides (scheme 1.4).132 Furoxans, formed by the dimerization of nitrile  
 
 
 
oxides, are troublesome byproducts and condition worsens when the excess of nitrile oxide is 
required to push the reaction to completion.133 Flash column chromatography is used to purify 
the isoxazoline product. Wilcox et al. hypothesized and successfully used precipitons for the 
isolation of isoxazolines from furoxan by product. To do so, first several alkenoates were 
attached to precipiton 3Z by an ester linkage (scheme 1.5). 
 
 
These were then subjected to cycloaddition with nitrile oxides in diethyl ether (scheme 1.6). 
After the reaction, the reaction mixture was washed with water and volatile components were 
removed. This residue was then dissolved in THF and Z/E isomerization of the precipiton  
auxillary was induced by adding diphenyl disulfide and heating the solution. The solvent was 
removed after isomerization, the crude residue obtained was washed with Et2O, MeOH, or 
hexanes to remove any by product, and sparingly soluble pure products were isolated by 
Scheme 1.4. A general scheme for the synthesis of isoxazolines by [3+2] cycloaddition reaction between 
alkenes and nitrile oxides.  
Scheme 1.5. Synthesis of precipiton bound alkene substrate for cycloaddition with nitrile oxide. 
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filtration. Precipiton-bound products were isolated in good yields and high purity (scheme 
1.7).  
 
 
 
 
 
 
Scheme 1.6.  A general scheme for the synthesis of precipiton bound isoxazoline product by [3+2] cycloaddition reaction 
between precipiton bound alkenes and nitrile oxides.  
 
Scheme 1.7. Illustration of the “precipiton” process for isoxazoline isolation. a) A solution of tert-butylnitrile is 
added to an ethereal solution of precipiton bound alkene. b) The Et2O is removed to afford a crude residue. c) The 
crude residue is diluted with THF and one equivalent of diphenyl disulfide was added. d) The solution is heated at 
reflux to cause isomerization and product precipitation. e) The THF is removed and the solid is washed with 
hexanes, Et2O, or methano; to afford clean solid.  
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Finally, precipiton was cleaved from the product by methanolytic transesterification in THF 
by methanol/triethylamine (scheme 1.8). The resulting methyl ester isoxazolines were 
obtained in high yields and purities.   
 
 
 
Precipiton-assisted isolation of α-substituted β-ketoesters: 
In order to demonstrate the usefulness and further extend the scope of precipiton method in 
separations technology, Wilcox et al. used precipitons in the separation of α-substituted β-
ketoesters.129 These are the family of compounds which serve as useful intermediates in the 
preparation of heterocyclic compounds134 and can also be chemoslectively and 
diasteroslectively reduced to form aldol-type products.135  
Acetoacetate ester 4Z was prepared by treatment of 3Z with diketene and catalytic amount of 
DMAP (scheme 1.9).  
 
 
Scheme 1.8. Methanolytic cleavage of the precipiton bound product to furnish precipiton E-3 and methyl ester of 
desired product. 
Scheme 1.9. Acetoacetate ester 4Z was synthesized by reacting precipiton 3Z with diketene in the presence of catalytic 
amount of DMAP. 
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The β-ketoester 4Z was deprotonated with sodium hydride to generate the enolate, which was 
then treated with an excess of alkylating agent. Upon completion of alkylation, the reaction 
mixture was partitioned between EtOAc and aqueous NH4Cl. The organic layer was 
evaporated and residue was dissolved in Et2O or CCl4 containing I2 and benzoyl peroxide to 
cause isomerization. Further work-ups and trituration of crude in ether, hexanes or methanol 
resulted in isolation of precipiton bound product in good yields and purities over 95% 
(scheme 1.10). 
 
 
 
The precipiton was then cleaved by methanolysis (MeOH/TEA in THF, reflux 1-2 h) (scheme 
1.11). This furnished the methyl β-ketoesters in good yields and high purities. 
 
 
Scheme 1.10. Synthesis and isolation of precipiton bound product. 1) Alkylation of 4Z to afford precipiton bound 
product. 2) Isomerization of reaction crude to yield precipiton bound product. 
Scheme 1.11. Methanolytic removal of precipiton to give free product. 
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Precipiton assisted purification of Baylis-Hillman adducts: 
The Baylis-Hillman reaction is a C-C bond forming reaction between an activated alkene and 
an aldehyde in the presence of a tertiary amine, tertiary phosphine, or chalcogenide (scheme 
1.12).136 To push the reaction to completion one of the components must be used in excess,137 
which, in turn, will require purification of the product by column chromatography. However, 
the precipiton approach provides the liberty to use excess of one of the reactants without 
having to run a column for purification. 
 
 
Acrylate 5Z was prepared by treatment of 3Z with acryloyl chloride in the presence of 
triethyl amine (scheme 1.13). The acrylate 5Z was treated with catalytic amount of   
 
 
DABCO and excess of aldehyde at room temperature.138 Upon completion of the reaction of 
the reaction the crude mixture was diluted with a suitable solvent and treated with I2 and 
dibenzoyl peroxide or PhSSPh.Various work-ups and trituration with hexanes, ether, or 
MeOH resulted in precipiton bound Baylis-Hillman producst in good yields and high purity 
(scheme 1.14). 
Scheme 1.13. Synthesis of precipiton acrylate 5Z by reacting precipiton 3Z and acryloyl chloride in the presence 
of TEA  
Scheme 1.12. A general scheme for the synthesis of Baylis-Hillman product by reaction of an aldehyde with an 
activated alkene. 
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The precipiton-bound Baylis-Hillman products were cleaved from the precipiton by  
hydrolysis (LiOH in THF-H2O). The acids were isolated by filtration of the insoluble 
precipiton, acidification of the solution, followed by extraction with EtOAc. Removal of the 
EtOAc furnished the desired acid in good yields and purities of ≥95% (scheme 1.15).  
 
 
 
1.4 Cyclen based receptors for pyrene dyes and their use in separation technology 
In 2005 our group synthesized a cyclen based receptor.9 This receptor had a macrocyclic 
structure and was comprised of four naphthylthiourea groups tethered to a cyclen core via an 
ester linkage (fig. 1.4). This receptor showed very strong and very specific affinity for the  
 
Scheme 1.14. Synthesis and isolation of precipiton bound product. 1) Reaction of 5Z with aldehyde in the 
prescence of catalytic amount of DABCO to furnish precipiton bound product. 2) Isomerization of reaction crude 
to yield pure precipiton bound product. 
 
Scheme 1.15. Hydrolysis of precipiton bound product in the presence of LiOH in H2O-THFto afford precpiton 
and product 
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 pyrene based dyes (HPTS, APTS, PTA) (fig. 1.4) under physiological conditions. Upon 
interaction with the dye, the receptor formed an insoluble complex which had micromolar 
stability (Ka-10
-6
), and the complex formation resulted in quenching of the dye fluorescence. 
Isothermal calorimetry (ITC) and molecular mechanics simulation identified π-stacking 
between the aromatic units of the receptor and the planar core of the dye as the major driving 
force for the complex formation (scheme 1.16). 
 
 
 
Figure 1.4. Structure of cyclen 1, HPTS, APTS and PTSA dyes. 
Scheme. 1.16. A) Envisoned binding mode for cyclen 1 and HPTS dye. The backside thiourea unit of cyclen 1 
is truncated for clarity. This representation is given for pictorial purpose only. B) Structure of cyclen 1-HPTS 
complex optimized by molecular mechanics (AMBER) simulations in the water box. Water molecule omitted 
for clarity.  
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Since this receptor-dye pair formed an insoluble complex of micromolar stability upon 
interaction, we decided to use this receptor-dye pair in developing a new separations 
technology. We reasoned that if the substrate of interest can be attached to the dye, this dye-
substrate conjugate then can be selectively precipitated from the reaction mixture by adding 
receptor in the reaction mixture. Alternatively, if this mixture is passed through a column 
carrying immobilized receptor on the solid support, the labeled substrate can be selectively 
purified. We hypothesized that this receptor-dye pair can be used in the selective separation 
of substrate by chemoselective precipitation as well as by affinity chromatography. This work 
is discussed in detail in the following chapters.  
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Chapter 2 
Synthesis of cyclen-based receptors for pyrene dyes 
2.1. Introduction 
In 2005, Winschel et al. were trying to develop a new biomembrane leakage assay,139 as the 
current assays had some inherent shortcomings. The liposome-based pH-stat fluorometric 
assay is an assay routinely used for identification of physiologically relevant ionophores.140, 141
 
In the context of this discussion, ionophores are the compounds that assist in the transport of 
ions across cell membranes. In this assay, a controlled amount of the base and potential 
ionophore is added to a suspension of liposomes containing a pH-sensitive dye, 8-
hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine),142-144 or sometimes fluorescein.145 The 
resulting pH gradient across the bilayer membrane causes the efflux of hydronium ions and 
builds up an electrostatic potential. This potential can be compensated by the efflux of anions 
or influx of cations. If the compound of interest mediates such ion transport, the efflux of 
hydronium ions continues altering the intravesicular pH and the fluorescence of the reporter 
dye. The kinetic trace obtained from the dye response thus reflects the ionophoretic activity 
of the studied compound.  
 
 
Scheme 2.1. A) pH-Stat experiment; B) Membrane leakage assay 
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 While being rapid and reliable, the pH stat assay provides little information on the 
mechanism of ion transport.146 A membrane leakage assay addresses some mechanistic 
aspects by distinguishing selective ion transport from nonslective leakage through oversized 
pores.147, 148 This assay utilizes the ability of calcein or carboxyfluorescein (CF) dyes to self-
quench their fluorescence emission at ~100 mM concentration.(ref) In a typical experiment, a 
set of large unilamellar vesicles (LUVs) containing the concentrated dye is challenged with 
the compound of interest. In the case of selective ion transport, little change in fluorescence is 
observed, whereas the larger pore formation results in the dye release, its subsequent dilution, 
and emission increase. However, this assay requires high concentration of the dye (100 mM) 
and at such a high concentration the membrane properties could be altered, as well as the 
buffer capacity, and interactions of the dye with ionophore become possible. Another assay 
used to detect endovesiculation requires high concentration (40mM) of quencher p-xylene-
bis-pyridinium bromide (DPX) (fig. 2.1).149
 
In such high concentrations DPX has been 
reported to affect the fluidity of negatively charged membranes, to alter the size of large 
unilamellar vesicles (LUVs), and to lower the bilayer phase transition temperatures.150 As a 
result, both above mentioned assays cannot deliver an accurate picture of the effects produced 
by the ionophore on the biological membrane. 
 
 
Therefore, we hypothesized that a compound capable of selective binding to the HPTS at 
micromolar concentrations, impermeable to the bilayer membrane, and capable of quenching 
HPTS fluorescence would provide the basis for improved assays. This led to the synthesis of 
Figure 2.1. Structure of DPX. 
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cyclen 1 receptor which binds to HPTS and quenches its fluorescence at micromolar 
concentrations under physiological conditions. To gain more information on the 
thermodynamics of the complexation process, a series of isothermal titration calorimetry 
(ITC) experiments were performed. ITC is a quantitative technique that can directly measure 
the enthalphy (∆H) of binding event, whereas the binding affinity (Ka) and, subsequently, the 
free energy (∆G) can be calculated through the fitting of the titration data into the binding 
isotherm. The last thermodynamic parameter, entropy (∆S), can be calculated through the 
subtraction of the free energy of binding from the enthalpy.  The stoichiometry of the 
complex formation can be accessed from the appearance of the binding isotherm. As a result, 
all important thermodynamic parameters can be obtained from a single ITC experiment. 
In the case of ITC titration of the solution of HPTS with the solution of cyclen 1, the 
formation of two distinct types of complexes was observed (fig. 2.2.A and 2.2.B).The 
assessed thermodynamic data for these complexes are summarized in Table 1. The first 
complex shows 1:1 stoichiometry, whereas the second complex corresponds to the overall 1:4 
HPTS/cyclen 1 stoichiometry. These two complexes have different strengths and are driven 
by different thermodynamic forces. The originally formed 1:1 complex is 2 orders of 
magnitude stronger than the subsequently formed 1:4 complex. Whereas the formation of the 
1:4 complex is an enthalpically driven process, the 1:1 complex formation is almost entirely 
an entropically driven process. The entropically driven 1:1 binding is consistent with the 
solvophobic effect most likely accompanying π- π rather than hydrogen-bonding or 
electrostatic interactions.151 A much weaker 1:4 complex formation is a mostly enthalpically 
driven process accompanied by a smaller positive entropy change. This second complexation 
step is probably due to the electrostatic and/or hydrogen-bonding interactions of cyclen 1 
molecules with the initially formed 1:1 complex. Although the solvophobic effect plays a role 
in the 1:4 complex formation as well, the diminished entropy change likely stems from the 
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decrease in the degrees of freedom for the large aggregate formed from several molecules. 
Noteworthy, no additional inflection points between 1:1 and 1:4 pyranine/cyclen 1 ratios 
were observed in the ITC plot, suggesting that the second binding process proceeds via a 
concerted cooperative mechanism.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1.  Thermodynamic Parameters Assessed for the Complexation of Pyranine with Cyclen 1 in Methanol 
N Ka(M
-1
) ΔG (kcal/mol) ΔH (kcal/mol) TΔS (kcal/mol)  
1.28 ± 0.014  (3.16 ± 0.75) × 10
6
  −8.87 ± 0.17  −0.41 ± 0.05  8.47  
3.57 ± 0.050  (1.46 ± 0.12) × 10
4
  −5.68 ± 0.05  −3.87 ± 0.08  1.81 
 
Figure 2.2. Microcalorimetric characterization of interactions of cyclen 1 with pyranine and calcein in methanol. (A) Raw 
data for the titration of a 0.25 mM solution of HPTS with a 10 mM solution of cyclen 1. (B) Integrated data from (A), 
corrected by the heat of cyclen 1 dilution, normalized to moles of injectant and plotted as a function of cyclen 1/pyranine 
ratios (solid squares). A continuous line represents the data fit in two sets of sites binding model. (C) Raw data for the 
titration of a 0.25 mM solution of calcein with a 10 mM solution of cyclen 1. Note the difference in vertical scales for plots 
(A) and (C). (D) Integrated data from (C), corrected by the heat of cyclen 1 dilution, normalized to moles of injectant and 
plotted as a function of cyclen 1/calcein ratios. 
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The specificity of the cyclen 1 towards the HPTS dye was further established by the lack of 
interaction of cyclen 1 with fluorescein-related dyes (fig. 2.3). These dyes are negatively 
charged and have aromatic cores like HPTS dye, however, these dyes are not planar as the 
benzene ring is tilted out of plane of the second aromatic unit. The π-stacking of these cores 
with the aromatic units of the cyclen 1 was not expected to be efficient, and indeed, the ITC 
titrations of calcein with cyclen 1 showed no apparent binding except protonation of the basic 
receptor with the acidic dye (fig. 2.2.C and 2.2.D). These experiments prove that the planar 
aromatic core of the dye is essential for its recognition by cyclen 1.   
 
 
2.2. Structure-activity relationship studies 
The original receptor cyclen 1 was comprised of four naphthylthiourea groups tethered to a 
cyclen core via ester linkages (fig. 1.4 structure of cyclen 1). This tetrafold macrocyclic 
structure of cyclen 1 with multiple functional groups placed into the specific positions was 
essential for HPTS recognition, as established by the results of various structure-activity 
studies. In the first study, the acyclic naphthyl thiourea 2 (fig. 2.4.A), which mimics the 
structure of a single arm of cyclen 1, was titrated into the solution of HPTS instead of cyclen 
1. This arm replica did not bind the dye to any measurable extent, proving the necessity of the 
Figure 2.3. Structure of various fluorescein dyes. 
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macrocyclic arrangement of the receptor for the dye recognition. Another study indicated that 
ester linkers are essential for the binding as ester groups coordinate to the physiologically-
abundant Na
+
 ion and bring the four arms closer to each other which further assists in the 
complexation of the dye.152, 153 Indeed, when receptor 3 (fig. 2.4.B) lacking ester linkages was 
used for HPTS binding, a 15-fold decrease in Ka values was observed compared to the cyclen 
1. This hypothesis was further supported by a three-fold drop in cyclen 1 affinity to HPTS in 
Na
+
-free buffer. In another study, NH-Boc synthetic precursor (fig. 2.4.C) showed no 
noticeable binding affinity to HPTS. This proved essentiality of the thio(urea) functionality as 
well as the terminal aromatic units for the recognition of the dye by the receptor. All these 
studies proved beyond any doubt that the receptor having a macrocyclic structure and 
specifically placed functional groups is essential for the recognition of the dye by the 
receptor. 
 
 
 
 
Figure 2.4. Structure of compounds used in structure and activity studies. A) acyl naphthyl thiourea 2 B) receptor 3 
C) Nh-Boc synthetic precursor   
 35 
 
2.3. Synthesis of new receptors 
The results of various structure and activity studies shed light on some interesting facts 
regarding necessity of macrocyclic structure of the receptor for the dye recognition. We 
further decided to explore the effects of structure of the receptor on its ability to bind the dye. 
The effects of various substituents on the aromatic unit of the receptor were not studied 
previously. Hence, a series of receptors having different X and R groups as shown in fig. 2.5 
were synthesized and their fluorometric titrations were carried out to determine their affinity 
towards pyranine dye. 
 
Receptors 4-8 were synthesized according to scheme 2.2. The synthesis began with N-Boc-
ethanolamine, which underwent a substitution reaction with bromoacetyl bromide to give 
compound i (step a) in 90% yield. The compound i was then subjected to substitution reaction 
with the cyclen to afford compound ii (step b) in 56% yield. We call compound ii as the 
precursor, as it was used to synthesize all the receptors 4-8, by reacting it with various 
isothiocynate compounds. Subsequent deprotection of the precursor with trifluoroacetic acid 
(TFA) furnished compound iii (step c) in 100% yield. The compound iii was used without 
Figure 2.5: Structure of various receptors synthesized having different X and R groups  
4 
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any purification in the synthesis of receptors 4-8. The compound iii was subjected to addition 
reaction under basic conditions with various isothiocynate to furnish receptor 4-7 and reacted 
with benzoyl chloride to yield receptor 8 in yields ranging from 22-76% (step d). 
 
 
2.4. Fluorometric titrations and results 
The receptors 4-8 synthesized according to the scheme 2.1 had different X and R groups. The 
receptors 4-7 have thiourea tethers but they have different R groups on the aromatic moieties. 
The receptor 3-5 varied in the electronic nature of the subtituent group attached to the 
aromatic ring e.g. receptor 4 had an electron-withdrawing nitro group on the aromatic ring, 
receptor 5 was bearing an electron-donating methoxy group on the aromatic ring and receptor 
6 had a weakly electron-withdrawing bromine atom on the aromatic unit. The receptor 7 
lacked the aromatic unit and had an n-butyl group attached to the thiourea group instead. The 
receptor 8 had an amide group instead of thiourea group. In order to understand the effect of 
these different groups on the binding ability of the receptor, fluorometric titrations were 
carried out. In a typical experiment, an aqueous solution (2 mL) containing 50 nM HPTS, 100 
Scheme 2.2. a) Bromoacetyl bromide, Et3N, CH2Cl2, rt, 5 hrs, 90%; b) cyclen, CH3CN, rt, 72 hrs, 56%; c) 
TFA/CH2Cl2, rt, 6 hrs; d) RNCX, i-PrOH/EtOH or THF, Et3N or i-Pr2EtN, 6-48 hrs, 22-76% 
 37 
 
mM NaCl, 10 mM NaxH3-xPO4 (x = 1, 2; pH 6.4) was placed in a thermostated 
spectrophotometric cell set at 25
0
C. The solution was gently stirred during the experiment. 
Prior to the spectrometric recording, 20μL of 25-5000 μM solution of receptors 4-8 in DMSO 
were added to the cell giving the final concentration of the receptors in the range of 2.5-500 
μM. The emission spectra were then recorded with the excitation wavelength of 405 nm. The 
emission maxima at 510 nm were monitored. Binding constant and the maximum emission 
loss with the confidence interval values were then computed (table 2.2) using a homemade 
nonlinear regression curve fitting program.   
 
Receptor cyclen 1         4            5           6          7         8 
Ka (M
-1) (2.6 ± 0.3) × 106  (7.2 ± 0.8) × 106 (9.0 ± 1.2) × 106 (4.2 ± 0.8) × 106 Not determined No interaction 
Imaxrel loss (%) 90.9 ± 1.6 98.5 ± 2.3 77 ± 1.1 93.3 ± 3.1 Variable 0 
 
The receptors 4 and 6 featured strong and weak electron-withdrawing groups respectively, 
and their affinity to HPTS was higher than that of cyclen 1 as indicated by their respective Ka 
and I
max
rel loss values. Receptor 4 with the strong electron-withdrawing nitro group turned out 
to be the most efficient receptor in terms of the fluorescence quenching.  HPTS dye is 
negatively charged due to the presence of three sulfonate groups and an OH group with low 
pKa. The electron-withdrawing groups remove electrons from the aromatic ring of the 
receptor’s arms, making them electron-depleted, which in turn resulted in a stronger π-
stacking of the receptor with the negatively charged HPTS dye.  
Interestingly, receptor 5, bearing an electron-donating methoxy groups on the aromatic ring, 
has also shown an increase in the affinity towards HPTS. While we didn’t have an exact 
explanation for this observation, we speculated that the receptor 5 has a higher affinity to Na
+
 
cation, which was essential for the proper arrangement of the receptor binding arms. Since 
Table 2.2. Binding constants and maximum fluorescence loss assessed for the complexes of HPTS with cyclen 
based receptors from Fluorometric titrations in PBS 
 
 
 
 
 
 
t 
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the actual affinity of ester groups to Na
+
 is not very high,152, 153 a certain portion of receptor 
molecules always remain uncoordinated and hence less efficient in terms of HPTS binding. In 
case of receptor 5, such a portion of molecules was lower than that for the cyclen 1, and more 
efficient apparent binding of the receptor 5 could be due to this more efficient Na
+
 
coordination. Although plausible, this explanation is a mere speculation as the further 
investigation of the observed phenomenon was beyond the scope of this study. 
 Receptor 7 showed variable fluorescence quenching at various concentrations which 
suggested that a complex binding mechanism was in operation. One possible explanation is a 
formation of complexes of a various stochiometries. We have already seen two types of 
complexes in case of HPTS and cyclen 1 binding (1:1 and 1:4). As the receptor has four 
binding arms and HPTS has six binding sites (four sulfonates and two faces of aromatic 
core), it is plausible that a series of complexes ranging from 6:1 (one dye and six receptor 
molecules) to 1:4 (one receptor and four dye molecules) can be formed. In all these 
complexes, the electronic environment of the dye is different which results in different extent 
of quenching. This is in line with the observed variation in the quenching extent as the 
receptor concentration was increased in titration series (fig. 2.6). 
 
 
Figure 2.6. Fluorometric titrations of 50 nM PBS solution of HPTS with receptor 7. Experimental data is normalized 
to the percentage of unbound dye fluorescence 
 39 
 
Receptor 8 had amide linkages in the place of thio(urea) linkages of the receptors 1-7, and it 
did not show any binding to the HPTS dye. This observation signifies the importance of 
thio(urea) group for the dye recognition by the receptor.  
2.5 Conclusions 
Receptor 4 and 6 with electron-withdrawing substituents were the better receptors, signifying 
the importance of π-stacking in the complexation process. The highest Ka value observed for 
the receptor 5 and lower quenching was somewhat intriguing and no exact explanation was 
possible for its complexation behavior.  Receptor 7 with butyl groups showed variable 
quenching extent in the titration series, attributable to the formation of several complexes 
with different stoichiometries. Receptor 8 lacking the thio(urea) group did not bind the dye, 
showing the essentiality of these groups for HPTS recognition.  
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Chapter 3 
Chemoselective Precipitation of Lactose from a Lactose/Sucrose Mixture: 
Proof of Concept for a New Separation Methodology 
3.1 Introduction 
Affinity chromatography,154
,
 155
,
 156
,
 157 immunoprecipitation158
,
 159
,
 160 and electrophoresis161
,
 162
,
 
163 remain the most common purification techniques for biological targets. Although the 
efficiency of these techniques has advanced to a level where virtually any biological substrate 
can be isolated in pure form, large scale purification of such substrates is cost-prohibitive.164
,
 
165 Furthermore, nearly all techniques, except for immunoselective precipitation,166 require a 
substantial excess of gel matrices or solid phase, which may pose environmental problems in 
association with large scale purifications. On the other hand, non-specific precipitation 
techniques such as protein salting out167
,
 168 or precipitation with glycine or trichloroacetic 
acid169 do not require excessive amounts of reagents yet they provide rapid large-scale 
isolation of crude mixtures of proteins. Obviously, such precipitation methods show little 
selectivity as they rely on non-specific desolvation of proteins that are present in the mixture. 
A precipitation methodology that does not require excessive amounts of components, yet is 
capable of targeting specific functional groups that are present or introduced into the 
substrate, may become a valuable addition to both highly selective microscale separations 
and nonselective large scale separation techniques. 
To our surprise, only a few examples of such chemoselective precipitation are known in 
literature1
,
 2 Of most prominent examples, precipitation of C60 with calixarenes and related 
macrocycles, developed by Atwood and coworkers, serves as a proof of efficiency of such 
methodology.3
,
 4 While being efficient, Atwood’s protocol lacks versatility as it is only 
applicable to a specific pair of substrate and macrocycle, and is not applicable to biological 
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substrates, which must be extracted from the aqueous medium. A precipitation methodology 
for isolation of non-biological targets has been introduced by Wilcox et al..127
,
 128
,
 129 In this 
methodology, a substrate of interest is allowed to react with a “precipiton”: an auxiliary 
stilbene-based molecule, solubility of which can be modulated by isomerization from highly 
soluble cis-form to insoluble trans-form. After the reaction, the conjugate is converted into 
insoluble form, the precipitate is collected, and the substrate in recovered through solvolysis. 
This methodology is applicable to isolation of lipophilic compounds, however, it cannot be 
used for separations of highly polar biological substrates due to the reaction conditions that 
require organic solvents of low polarity.  
While our new methodology utilizes purification approach similar to that described by 
Wilcox, this methodology is developed for aqueous medium and therefore especially suitable 
for isolation of biological substrates.  
Recently, we identified a family of artificial cyclen-thiourea receptors that form complexes 
with pyrene-based dyes under near-physiological conditions.9
,
 170 These complexes feature 
micromolar stability and diminished solubility in water and methanol compared to the 
intrinsic solubility of the dye and receptor alone.9 More interestingly, the cyclen-based 
artificial receptors were highly selective for the pyrene scaffold, while at the same time 
tolerating considerable structural variations in peripheral positions on the dye. We reasoned 
that the conjugates of these dyes with biological substrates should form insoluble complexes 
with the cyclen-thiourea receptors and afford selective separation of the desired target. 
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3.2 Irreversible labeling of lactose with APTS and its chemoselective separation from 
lactose/sucrose mixture 
Here, we report the proof of concept for the chemoselective precipitation of biological 
substrates using a model system of two disaccharides: lactose and sucrose. While the physical 
properties of these sugars are very similar,171 which makes their separation by common 
techniques difficult,172
,
 173 the presence of a reducing end in lactose allows a test of our 
principle. 8-Aminopyrene-1,3,6-trisulfonic acid (APTS) is the dye that forms a stable 
complex (Ka =  8x10
5
 M
-1
) with the naphthyl thiourea cyclen receptor (cyclen 1, Scheme 
3.1).9 The presence of an amino group in this dye implies that it can be readily tethered to the 
reducing end of lactose via reductive amination reaction.  
The combined schematic representation of chemoselective precipitation protocols is shown 
on scheme 3.2. 
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First, we demonstrated that the lactose-APTS conjugate can be precipitated out from the 
solution by interacting with cyclen 1 in the presence of sucrose. As detailed in the 
experimental section, the reductive amination reaction between lactose and APTS was 
performed according to the literature procedure174
,
 175 and the conjugate was purified on an 
anion-exchange column. Then, we developed a procedure that allows precipitation of this 
conjugate through interaction with cyclen 1. The most efficient results were achieved when a 
1 mM solution of lactose-APTS conjugate in H2O:MeOH (1:9) was mixed with an equal 
volume of 2 mM cyclen 1 solution in the same solvent system. At these concentrations, both 
lactose-APTS conjugate and cyclen 1 were completely soluble. However, the interaction 
between these two components resulted in formation of a precipitate and almost complete 
discoloration of the originally bright greenish solution (fig. 3.1.a). The fluorometric analysis 
suggested that at least 89% of the lactose-APTS conjugate was precipitated from solution 
(fig. 3.1.b).  
Scheme 3.2 General representation of protocols for chemoselective precipitation and isolation of lactose and 
sucrose from a lactose/sucrose mixture.  
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To test the selectivity of precipitation, a sample of APTS-labeled lactose was mixed with 
sucrose (1 eq.), dissolved in H2O:MeOH (1:9), followed by the addition of a solution of 
cyclen 1 (2 eq.). A precipitate immediately formed, which was removed by centrifugation, 
suspended in water and back-extracted with chloroform. This back-extraction led to 
repartitioning of cyclen 1 into the organic layer, thereby releasing APTS-labeled lactose in 
the aqueous layer. Comparison of the 
1
H NMR spectra (fig. 3.2) of the mixture of sucrose and 
labeled lactose (spectrum 1), the supernatant following precipitation (spectrum 2) and the 
back extracted aqueous solution (spectrum 3) shows the chemoselective precipitation 
phenomenon. It is important to note that the precipitation and release is highly selective and 
almost quantitative as evidenced by the absence of APTS signals in spectrum 2 and cyclen 1 
signals in spectrum 3. The aromatic signals observed in the supernatant correspond to a partly 
dissolved excess of cyclen 1. The aromatic region shows signals of APTS label with no traces 
of cyclen 1. Also note the absence of acetal signal for sucrose at 5.4 ppm in this spectrum. 
 
 
 
Figure 3.1. a) Image of 1 mM solution of APTS-lactose conjugate in the absence (left vial) and in the presence 
(right vial) of 2 mM cyclen 1. Note a precipitate formed in the right vial upon application of cyclen 1; b) 
Emission spectra of lactose-APTS conjugate (ex = 424 nm) before and after the treatment with cyclen 1. Top 
spectrum was recorded for 1 μL of 1 mM solution of lactose-APTS conjugate in H2O:MeOH (1:9) injected into 
20 mL of water.  Bottom spectrum was recorded for 2 μL of the supernatant formed upon mixing of lactose-
APTS conjugate and cyclen 1 solutions, diluted into 20 mL of water. 
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To demonstrate that lactose can be selectively removed from the sucrose-lactose mixture via 
the two step labeling – precipitation protocol, we then chose to carry out labeling with 
disaccharide mixture, rather than mix pre-labeled lactose with sucrose. Unfortunately, 
labeling of lactose with equimolar amounts of APTS dye was too slow, and sucrose 
underwent acid-catalyzed hydrolysis during this time. When a five-fold excess of APTS was 
used in the reductive amination, a rapid (within 2 hours) labeling of lactose took place 
without any detectable sucrose degradation. Even though the resulting mixture was more 
complex than a mixture of labeled lactose and sucrose, the additional component in this 
mixture was APTS dye, which was also a target substrate for cyclen 1. Application of two-
fold excess of cyclen 1 (with respect to the total amount of APTS) resulted in a complete 
removal of APTS and APTS-lactose conjugate, leaving sucrose as the only soluble 
component in this mixture (fig. 3.3). Almost 70% of sucrose was recovered. 
5.25.45.65.86.06.26.46.66.87.07.27.47.67.88.08.28.48.68.89.09.29.4
9.0 8.5 8.0 7.5 7.0 6.5 6.0
 5.5 
3 
2 
1 
APTS cyclen 1
 sucrose 
Figure 3.2.
 1
H NMR spectra (D2O) of 1) labeled lactose and sucrose mixture; 2) supernatant 
formed upon treatment of the mixture with cyclen 1 and 3) aqueous portion of precipitate 
after back-extraction with CHCl3. 
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3.3 Reversible labeling of lactose with APTS and recovery of all the components used 
for the chemoselective precipitation   
The protocol for chemoselective precipitation that relies on the reductive amination reaction 
leads to the irreversible labeling of the target molecule. Formation of an imine bond from the 
same carbonyl group and the amino group of the dye would introduce the label that could be 
hydrolyzed back to the original substrate after chemoselective precipitation. This Schiff-base 
chemistry has been recently used for the reversible attachment of proteins to the solid 
matrix.176 In order to test such possibility we have developed an additional protocol to label 
lactose with APTS via an imine tether. Due to the reversibility of imine bond formation, the 
labeling of carbonyl compounds is an equilibrium process, and an excess of the amino 
compound is required in order to label most of the substrate. Even though such an approach 
results in a mixture comprising at least three components (free excess label, a conjugate and 
label-free substrate), our new protocol solves the problem of irreversible modification. 
 APTS sucrose lactose 
1 
2 
3 
4 
5 
3.54.04.55.05.56.06.57.07.58.08.59.09.510.0
Figure 3.3. 
1
H NMR spectra (D2O) of 1) APTS, lactose, sucrose and NaBH3CN mixture prior to the reductive 
amination reaction; 2) same mixture after two hours of the reduction; 3) same mixture after treatment with cyclen 
1. Please note disappearance of all peaks except those produced by sucrose; 4) sucrose; 5) lactose. 
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First, a mixture of lactose and APTS dye was dissolved in a small volume of 1 M solution of 
acetic acid and stirred for 12 hours, producing lactose-APTS imine conjugate and excess of 
free dye, as evidenced by 
1
H NMR. Then, an excess of cyclen 1 was applied to this solution, 
causing precipitation of labeled lactose and lactose-free dye. This precipitate was collected 
and subjected to hydrolysis with a large volume (3 mL) of 2 M aqueous acetic acid. Under 
such conditions, the precipitate was immediately dissolved. After 2 hours of stirring, the 
solvent was removed under vacuum, and 1 mL of 1 N aqueous ammonia was added to the 
solid residue and back extracted with chloroform. The 
1
H NMR analysis of organic and 
aqueous layers showed that only cyclen 1 was present in chloroform, and a mixture of lactose 
and APTS were found in the aqueous layer. Finally, lactose was separated from the APTS 
dye by the second application of cyclen 1, which resulted in precipitation of cyclen 1 and 
APTS dye, and left lactose as the only component in aqueous layer. Resuspension of the 
precipitate in water and back extraction with chloroform separated cyclen 1 from APTS (fig. 
3.4) 
 
 
 
With this new protocol, not only could lactose be isolated in an unaltered form, but the dye 
and cyclen 1 were recovered as well.  
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
Figure 3.4.  
1
H NMR spectra of 1) reaction mixture comprising lactose and APTS dye in D2O; 2) recovered 
lactose in D2O; 3) recovered APTS dye in D2O and 4) recovered cyclen 1 in DMSO-d6. 
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An attempt of separation of lactose from sucrose in an unmodified form reached only partial 
success. While the isolated precipitate gave pure lactose after hydrolysis and back extraction, 
the supernatant showed sucrose contaminated with some residual lactose. Apparently, 
precipitation of lactose was not complete because of the reversible nature of the imine bond, 
which set the equilibrium between labeled and label-free disaccharide. Although the 
methodology of separation that relies on the temporary labeling via imine bond did not allow 
us to separate both sugars in the pure form, it can still be used for isolation of reducing 
sugars. In case if non-reducing sugars are the target substrates, they can be separated from the 
reducing components via permanent labeling of the latter via amine bond. 
Since many sugars possess reducing ends, a similar methodology can be applied to their 
separation. One example of practical value is the separation of low molecular weight 
heparin177. Heparin oligomers contain reducing ends178  and therefore can be labeled with 
APTS dye and complexed with cyclen 1. The overall solubility of such complexes should 
depend on the length of the heparin oligomers, where the complexes of the shortest oligomers 
will be the least soluble and the complexes of the longest oligomers will be the most soluble. 
Our preliminary studies indicated that labeling of a heparin digest with APTS, followed by 
the treatment with cyclen 1 resulted in a partial precipitation of heparin conjugates, the extent 
of which was dependent on the solvent composition. Chemoselective precipitation of heparin 
oligomers will be the focus of our future studies.  
 
3.4 Conclusions 
We developed a facile method for separation of biomolecules via tethering them to the APTS 
dye and subsequently applying to these conjugates a synthetic receptor cylen 1, which binds 
to the APTS label. Due to the low solubility of the APTS-cyclen 1 complex, the APTS 
conjugate precipitates out from the solution upon interaction with cyclen 1, thus leaving 
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unlabeled molecules as the only soluble components in the mixture. Whereas tethering of 
carbonyl-containing compounds to APTS via the reductive amination reaction makes them 
permanently labeled with APTS, the attachment of APTS through an imine bond allows for 
release of the precipitated molecule in the label-free form. Subsequent extraction of 
supernatant with organic solvent provides a means for the recovery of all components used 
for the chemoselective precipitation. This feature makes our new approach especially 
attractive for the large-scale separations of biological molecules. Separation of low molecular 
weight heparin oligomers is the focus of our future studies. 
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Chapter 4 
Immobilization of cyclen based receptors for pyrene dyes on solid supports: 
Beginning of a new affinity chromatography technique 
4.1. Introduction 
The successful use of dye-receptor pair in chemoslective precipitation of lactose from 
sucrose10 encouraged us to further explore the use of this dye-receptor pair in separations 
technology. In order to broaden the scope of this dye-receptor pair in separations technology, 
we decided to use this pair in affinity chromatography. We hypothesized that if a receptor 
having a functional group on the cyclen core can be synthesized, then this receptor can be 
immobilized on a solid support using this functional group. The receptor for pyrene dyes, 
immobilized on the solid support will be used as selection auxiliary for affinity 
chromatography. We expected that the substrates conjugated with the pyrene dyes will 
exhibit elongated retention times due to the specific interactions of the label with the solid 
support. This approach might prove itself as valuable means for purification of biological 
substrates, since the pyrene labels are commonly used in biotechnology for marking the 
targets of interest.179, 180 
4.2 Synthesis of p-NO2-Bn-Cyclen (core cyclen 9a) 
A functionalized receptor was required for the immobilization of the receptor on the affinity 
matrix. The p-NO2-Bn-Cyclen (core cyclen 9a), which has nitro benzyl group attached to the 
cyclen core can be used for the synthesis of functionalized receptor. Reduction of nitro group 
to an amine group will provide a reactive group which can be used for the immobilization of 
the receptor on various affinity supports. Although, this reagent was commercially available, 
we decided to synthesize it because of its high cost. Synthesis of p-NO2-Bn-Cyclen (core 
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cyclen 9a) had been reported by Oliver Renn et. al.191 They synthesized it according to 
scheme 4.1. 
 
 
Scheme 4.1. Reaction scheme for the large scale synthesis of  p-NO2-Bn-Cyclen (core cyclen 9a) from 
nitrophenylalanine 
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In this scheme a number of intermediates e.g. compound F, G and H (p-NO2-Bn-Cyclen), 
required HPLC purification making it an expensive process. We significantly modified this 
scheme and successfully developed conditions where normal chromatography can be used for 
the purification of the compound F and G. In the last step of the synthesis where detosylation 
was done to synthesize compound H (p-NO2-Bn-Cyclen), barium hydroxide was used to 
neutralize the excess sulfuric acid. Barium hydroxide is a very corrosive compound and can 
cause severe burns. We replaced it with less harmful potassium carbonate. A lot of solid was 
generated when potassium carbonate was added to the reaction mixture. This solid was stirred 
with chloroform to extract the compound H (p-NO2-Bn-Cyclen) from the solid. Thus, we 
successfully developed an extraction procedure for the isolation of final product instead of 
reverse phase HPLC purification as used in the literature. These changes in the synthetic 
procedure significantly reduced the cost of production of p-NO2-Bn-Cyclen (core cyclen 9a). 
4.3. Synthesis of functionalized receptor 
Functionalized cyclen receptor 11 was synthesized according to the scheme 4.2. 9 It was the 
same scheme used for the synthesis of the receptors 4-8 (see chapter 2), except that p-NO2-
Bn-Cyclen (core cyclen 9a) was used instead of cyclen. The synthesis started with the 
recognition arm (step a), followed by its attachment to the core cyclen 9a (step b) to furnish 
the precursor 9, which was then deprotected under acidic conditions (step c) and reacted with 
4-methoxyphenyl isocynate to yield functionalized OMe receptor 10 (step d). 
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The core cyclen 9a is an expensive compound and it was involved in the second step of the 
synthesis, followed by two more steps before the functionalized receptor 10 was obtained. As 
a result, even though the reasonable yields were acquired for the last three steps, the overall 
conversion of cyclen 9a was unacceptably low.  
Therefore, we decided to use an alternative scheme (scheme 4.3) which involved the use of 
cyclen 9a only in the final step of the receptor synthesis. This alternative synthesis started 
with the addition of 4-methoxyphenyl isocynate to ethanolamine (step a) to yield a partial 
Scheme 4.2: a) Bromoacetyl bromide, Et3N, CH2Cl2, rt, 5 hrs, 90%; b)  functionalized cyclen, anhydrous 
DMF, K2CO3, First 6 hrs 60
0
C followed by rt overnight, 55% ; c) TFA/CH2Cl2, rt, 6 hrs; d) 4-methoxyphenyl 
isocyanate, isopropanol/CH3CN, Et3N, rt, 16hrs, 40%. Overall yield: 22% in core cyclen 9a conversion. 
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arm 10a in almost 100% yield. It was then reacted with bromoacetyl bromide to furnish a 
complete arm 10b in 90% yield. The “complete arm” 10b was then attached to the core 
cyclen 9a to afford functionalized OMe receptor 10 in a 62% with respect to the core cyclen 
9a conversion. This was almost threefold increase in the procedure efficiency, comparing to 
the original route outlined in the scheme 4.2. Several reaction conditions such as use of 
different bases (organic and inorganic), different solvents, different reaction times and 
different temperatures were tried to optimize the yield. The best results were obtained when 
the step c was carried out in dry DMF at room temperature for six hours in the presence of 
K2CO3. 
Additionally, new synthetic route has not only increased the yield but it also simplified the 
overall procedure, as no purification was needed in the first step and the partial arm 10a was 
used as such in the step b for the synthesis of complete arm 10b. 
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The nitro group of functionalized OMe receptor 10 was then reduced to yield the final 
functionalized OMe receptor 11. Several attempts to reduce the nitro group with reduction 
procedures such as Na2S2O4, Ni/H2, Co/H2, NaBH4, Ni/H2 in the presence of NaBH4 have 
either failed or gave unacceptably low yields on the target compound. Finally, the Sn/HCl(g) 
reagent was used for the reduction. The drawback of this reagent was in the fact that each arm 
of the receptor had an ester linker susceptible to the acidic hydrolysis in the presence of 
moisture. However, by choosing proper conditions and apparatus design, we were able to 
successfully reduce the nitro group in a 63% yield (scheme 4.3). 
 
 
Scheme 4.3. Synthesis of the receptor 11. a) ethyl acetate, rt, 1hr, 97%; b) bromoacetyl bromide, Et3N, CH2Cl2, rt, 5 
hrs, 90%; c) anhydrous DMF, Na2CO3, rt, 6 hrs, 62%; d) anhydrous THF, Sn/HCl(g), rt, 4hrs, 63%. 
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4.4 Immobilization of functionalized receptor on solid support  
 Selection of solid support is a very important consideration in affinity systems. To be an 
adequate support, the matrix should be functionalized (so that the receptor can be 
immobilized using these functional groups), it should not show any significant nonspecific 
interactions neither with the target substrate nor with the receptor. The receptor is positively 
charged due to the cyclen core and the dye has negative charge due to the sulfonate groups. 
Thus, a neutral resin would be the most suitable support for immobilization, as it diminishes 
the nonspecific interactions between both the resin and the dye, as well as the resin and the 
receptor. Prior to the immobilization of the receptor, a series of fluorometric experiments of 
the matrix were carried out to ascertain the suitability of the given matrix for the affinity 
chromatography.  In a typical experiment, emission spectra were recorded for a 50nM HPTS 
solution in the presence of the resin and (or) receptor at an excitation wavelength of 405 nm.  
Benzaloxy benzaldehyde resin has an aldehyde group which can be used for the 
immobilization of the receptor 11 by the reductive amination. However, fluorometric 
experiments (fig. 4.1.A) showed unacceptable interactions with the HPTS dye.  The 
fluorescence intensity of HPTS solution decreased proportionally to the amount of resin 
added to the fluorometric cell (fig 4.1.A, traces 1 and 2 from the bottom). This could be due 
to the π-π stacking of the aromatic groups of the resin with the aromatic core of the HPTS. 
Therefore, it was not used for immobilization of the functionalized receptor.  
Benzenesulfonyl chloride resin has reactive sulfonyl chloride groups which can react with the 
receptor 11 to form a sulfonamide bond. However, fluorometric experiments (fig. 4.1.B) 
showed undesirable interactions of the resin with the receptor. Whereas little change in 
fluorescence of HPTS was observed in the presence of the resin alone (fig 4.1.B, traces 2 and 
3 from the bottom), a significant increase in fluorescence was observed in the presence of 
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receptor 11 and the resin (fig 4.1.B, trace 4 from the bottom). This was opposite to the effect 
produced by the receptor 11 on the fluorescence of HPTS in the absence of the resin (fig 
4.1.B, trace 1 from the bottom), where almost complete fluorescence quenching was 
observed. These results strongly suggest that the resin was interacting either with receptor 11 
or with the receptor 11-HPTS complex. In both cases, this made the sulfonyl chloride resin 
unsuitable for our purposes. The observed results with the sulfonyl chloride resin can be 
rationalized in the following way: Once placed under physiological conditions, the sulfonyl 
chloride groups were likely hydrolyzed to produce anionic sulfonic acid residues. While the 
anionic nature of the resin ensured the lack of interactions with the anionic HPTS dye, the 
cationic receptor 11 interacted with the resin via either electrostatic or electrostatic and π-π 
stacking interactions. Therefore, this resin was not used for immobilization of the receptor 11.  
Next, we decided to look at the epoxy-functionalized resin, which can be used for 
immobilization of receptor 11 via nucleophilic ring opening. The hydroxide groups, formed 
upon the ring opening are neutral under physiological conditions, which is an ideal case for 
the lack of undesirable interactions between the resin and the dye or receptor. Indeed, no 
significant change in fluorescence was observed for the solution of HPTS in the presence of 
the resin (fig. 4.1.C, traces 3 and 4 from the bottom), whereas the fluorescence quenching by 
receptor 11 was almost identical in the presence and in the absence of the resin. A small 
increase in the fluorescence intensity in the presence of the resin can be explained by the light 
scattering caused by relatively large resin beads. We concluded that the epoxy resin could 
potentially serve as a solid support for immobilization of receptor 11. 
Dowex Mac-3 ion exchange resin has carboxylic acid functional groups which can be used to 
attach receptor 11 by forming an amide bond. Due to the inherent anionic nature, this resin 
was not expected to interact with HPTS dye. The fluorometric experiments for this resin (fig. 
4.1.D) showed the results very similar to those observed for the epoxy resin: the Dowex Mac-
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3 alone produced little effect on the fluorescence of HPTS dye (fig. 4.1.D, traces 3 and 4 
from the bottom), whereas the quenching efficiency of receptor 11 was not altered by the 
addition of the resin to a significant extent (fig. 4.1.D, traces 1 and 2 from the bottom), 
suggesting that the resin did not interact with either the dye or receptor 11. 
Both the epoxy- and Dowex Mac-3 resins were potentially suitable for use as solid supports, 
however, several attempts to immobilize the receptor 11 on these resins failed. We concluded 
that relatively less reactive functional groups on the resins, heterogeneous reaction 
conditions, less reactive aromatic amine group of the receptor and steric hindrance could be 
the factors causing problems in the immobilization step.  
 
 
 
 
 
 
 
A 
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4.5 Synthesis of functionalized receptor with a spacer arm 
In order to overcome the above mentioned problems likely arising from the steric hindrance 
at the surface of the resins, we decided to attach a spacer arm to the aromatic amine of the 
receptor which would have a primary amine on the free end. Such a modification of receptor 
11 was expected to benefit the coupling reaction in a dual way: first, this spacer was expected 
to reduce the crowdedness around the reactive moiety; second, the less nucleophilic aromatic 
amino group would be conceptually substituted for the much more nucleophilic primary 
aliphatic amino group.  
The spacer arm was attached by a two step synthesis (scheme 4.4.2.) In the first step, receptor 
11 was reacted with succinic anhydride to give compound 12 in 80% yield. It was then 
reacted with N-Boc-1,3-propanediamine in the presence of 1-Ethyl-3-(3-
dimethyaminopropyl)carbodiimide (EDC) and catalytic amount of DMAP (15 mol%) to 
D 
Figure 4.1. Raw fluorescence data for 50 nM solution of HPTS in the presence of the resins and (or) receptor 
11. The excitation wavelength was set at 405 nm in all experiments. A) Benzoyloxy benzaldehyde resin; B) 
Sulfonyl chloride resin; C) Epoxy resin; D) Carboxylic acid (Dowex Mac-3) resin. 
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afford receptor 13 in 60% yield. N-Boc-1,3-propanediamine was synthesized by mono boc 
protection of propylene diamine according to scheme 4.4.1.  
 
 
 
4.6 Immobilization of the receptor 13 
Receptor 13 was deprotected and subjected to immobilization reaction on the acid and epoxy 
functionalized resins. However, all these attempts to immobilize the receptor failed. 
In addition to the resins discussed above, other functionalized solid supports are 
commercially available. One such support was NHS activated agarose, which was also 
potentially suitable for the coupling with the receptors 11 or 13. First, we selected less 
nucleophilic and more sterically crowded receptor 11 for the immobilization, as the more 
cost-efficient precursor among these two. Immobilization was attempted according to scheme 
4.5 and the reaction was monitored by thin layer chromatography (TLC). TLC showed 
Scheme  4.4.1. Synthesis of N-Boc-1,3-propanediamine. a) Boc anhydride, rt, 6 hrs. Scheme  4.4.2. Synthesis of  
receptor 13. a) Succinic anhydride, THF/CH3CN, rt, 12 hrs, 80%; b) N-Boc-1,3-propanediamine, EDC, DMAP, DMF, 
rt, 18 hrs. 
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formation of one new spot and disappearance of the starting receptor from the reaction 
mixture. This new spot was due to the formation of N-hydroxysuccinimide. TLC analysis 
indicated that the reaction was complete in 16 hours  
                          
 
 
4.7 Fluorometric titrations of receptor 11 immobilized on the solid support 
We successfully immobilized the receptor 11 on the solid support. A series of fluorometric 
experiments (fig. 4.2) were performed in order to ascertain the effectiveness of this new 
affinity chromatography matrix. As discussed above, the unmodified resin produced little 
effect on the fluorescence of HPTS dye (fig. 4.2, traces 3 and 4 from the bottom). In contrast, 
the resin with immobilized receptor 11 caused almost complete fluorescence quenching upon 
addition to the solution of HPTS. The fluorescence quenching caused by the immobilized 
receptor 11 was even stronger than the fluorescence quenching caused by the same amount of 
the resin-free receptor 11 (traces 2 and 1 from the bottom, respectively). The residual 
fluorescence of HPTS in the presence of resin-free receptor 11 was due to the intrinsic 
fluorescence of receptor 11-HPTS complex. Although low, this fluorescence has measurable 
intensity and is detectable regardless of the amount of the receptor added to the solution. 
Scheme 4.5. Immobilization of receptor 11 on NHS activated agarose.  TLC of reaction mixture at various intervals of times 
as visualized under UV lamp. Spot on far left, reaction at time T=0, Middle spot a co spot of reaction mixtur at time T=0 and 
time T=16 hrs, Spot on far right, reaction at time T=16 hrs.  
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Unlike with the resin-free receptor 11, the immobilized receptor caused a specific adsorption 
of the dye on the surface of the resin, thus providing its removal from the solution, which was 
consistent with the complete loss of fluorescence. 
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4.8 Conclusions     
We successfully synthesized cyclen receptors 11 and 13, suitable for immobilization on the 
solid support for the production of the affinity chromatography matrices. We reported two 
different routes for the synthesis of receptor 11 while developing a simpler and more 
productive scheme 4.3. We reported a 2.8 fold increase in the yield by using this alternative 
scheme for the synthesis of receptor 10. We have analyzed several different resins for their 
suitability as solid supports, and we identified NHS-activated agarose as the most appropriate 
candidate for these purposes. We successfully immobilized receptor 11 on NHS-activated 
agarose via amide coupling. The affinity matrix obtained showed specific affinity towards 
HPTS dye in the fluorometric experiments, which makes it suitable for the separation of 
HPTS-labeled biological substrates. 
Figure 4.2. Raw fluorescence data for 50 nM solution of HPTS in the presence of the resin and (or) free or 
immobilized receptor 11. The excitation wavelength was set at 405 nm in all experiments. 
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Chapter 5 
Future Work 
5.1 Introduction 
We successfully immobilized receptor 11 on NHS activated agarose. Initial results from   
fluorometric experiments indicated that the affinity support was very effective and a 
fluorescence quenching up to 95% was observed. The applicability of this matrix for the 
separation of various systems will be studied. 
5.2 Separation of a mixture of dyes 
We designed this affinity support for the separation of substrates conjugated with the pyrene-
based dyes (HPTS, APTS, PTA etc) (fig. 1.3). First, we will check the efficiency of the 
affinity matrix for the separation of the mixture of the dyes, where one dye will be a pyrene-
based dye, and the other dyes will have a different nature. Anionic fluorescein-based dyes 
will be added to the mixture to assess the specificity of the affinity matrix, cationic dyes, such 
as safranin O181 will be used as a negative control. The resolving efficiency of the affinity 
matrix will be quantified through the ratios of the retention times for the pyrene-based dyes 
and their nonbinding counterparts. The elution profiles and the holding capacity of the matrix 
will be assessed as well. 
5.3 Separation of low molecular weight heparin (LMWH) 
 
Figure 5.1 Major repeating disaccharide of heparin 
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Heparin is a linear polysaccharide consisting of uronic acid-(1→4)-D-glucosamine repeating 
disaccharide subunits (fig. 5.1) having a high degree of sulfation and acetylation.182 Heparin 
is used as an anticoagulant. Unfractionated heparin is a heterogeneous mixture of 
polysaccharide chains ranging in molecular weight from 3000 to 30,000. LMWH are 
produced by controlled enzymatic or chemical depolymerization (scheme 5.1) of 
unfractionated or large molecular weight heparins, followed by size and affinity separation.183 
They have an average molecular weight of about 5000. Both unfractionated and LMWH are 
effective antithrombic therapeutics, but frequent use of unfractionated heparins can cause 
thrombocytopenia.184 In contrast, LMWH are found safer to use. Also, outpatient treatment of 
conditions such as deep vein thrombosis and pulmonary embolism is possible with LMWH 
compared to necessary hospitalization as needed for treatment with unfractionated heparins. 
Therefore, use of LMWH is both safe and financially beneficial. Hence, a simple method for 
separation of LMWH will be of great practical interest. 
 
 
Since chemical and enzymatic depolymerization produce fragments having single reducing 
ends, APTS can be coupled with these fragments by reductive amination. These labeled 
fragments can be then purified using receptor immobilized affinity supports. The 
immobilization of receptor 11 was performed in DMF/H2O solvent system; once all the 
Scheme 5.1. a) acid catalyzed b) enzymatic depolymerization of heparin 
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receptor is immobilized, remaining NHS-ester groups will be hydrolyzed and carboxylic acid 
groups will be produced. The carboxylic acid groups produced are negatively charged and 
heparin itself is negatively charged due to the sulfate groups. As a result, both resin and 
heparin will repel each other. This repulsion will be more pronounced between the large 
heparin fragment and the resin and hence a differential binding will be achieved. The larger 
the pyrene conjugated heparin fragment is, the weaker binding to the affinity support will be 
expected. This variable binding affinity will be used to develop specific elution protocols for 
the effective separation of LMWH. 
5.4 Mapping of cells expressing ligand-gated ion channels 
Ligand-gated ion channels are a group of transmembrane proteins. These have specific 
binding sites for ligands, such as neurotransmitters.185 Once bound to the ligand the ion 
channel opens up and influx or efflux of ions occurs which in turn plays an important role in 
many physiological processes. These ligand-gated ion channels are related to various diseases 
such as schizophrenia, depression, attention deficit, hyperactivity disorder, Alzheimer’s 
disease and of course, tobacco addiction.186-189Thus, location of these ligand-gated ion 
channels and study of mechanism of ion transport is of great significance in finding a cure for 
these diseases.  
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We have synthesized receptor 12 (fig. 5.2) which bears a carboxylic group attached to 
the cyclen core. This receptor will be reacted with 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) to produce a modified lipid bearing a receptor 
molecule. This lipid will be then incorporated into the liposomes filled with the 
reporter dye. Several neurotransmitters such as acetylcholine, nicotine, GABA etc 
have been identified as ligands for the receptors on the ligand-gated ion channels. 
These ligands will be coupled with the pyrene based dyes. The effectiveness of these 
dye conjugated ligands will be determined by adding these into the cells bearing 
ligand-gated ion channels. If the dye-ligand conjugate shows effective binding then 
the suspension of liposomes bearing a surface-anchored receptor will be added to 
these cells. The receptor will bind to the pyrene portion of the ligand conjugate which 
in turn attaches the liposome to the ligand-gated ion channels.  Since liposomes will 
be filled with the reporter dye, a single receptor  on ligand-gated ion channels can be 
detected by this fluorescence amplification.  
Figure 5.2. Structure of receptor 12. 
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This work has opened several new venues and applicability of this dye-receptor pair in the 
fields of biochemistry, pharmacology, cell biology etc. will be explored. 
 
 
 
 
 
Scheme 5.2. A general scheme for the detection of ligand-gated ion channels 
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Experimental Section 
General Methods: 
All the chemicals and solvents were purchased from Sigma-Aldrich (Milwaukee, WI), Acros 
Organics or Fisher Scientific (Pittsburgh, PA) and used without further purification. The 
column chromatographic separations were performed with silica gel 60 (230-400 mesh). All 
1
H NMR and 
13
C NMR spectra were recorded on Varian 300 and 400 MHz NMR 
spectrometers. All NMR chemical shifts (δ) were reported in parts per million (ppm) and 
were determined relative to the standard values for deuterated solvents. Electro spray 
ionization mass spectroscopy (ESI-MS) analysis was carried out using a Q-TOF2 from 
Micromass (Manchester, U.K.). All spectrophotometric experiments were carried out on a 
Fluoromax 3 (Jobin-Yvon/Horiba) spectrophotometer.    
Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester (i). tert-Butyl-N-(2-hydroxy ethyl) 
carbamate (4.5 g, 28 mmol) was dissolved in dichloromethane (30 mL), and triethylamine 
(3.9 mL, 28 mmol) was added. The mixture was stirred for 10 min at room temperature, and 
bromoacetyl bromide (3.15 mL, 36 mmol) was added dropwise within 5 min. The reaction 
mixture was stirred for 5 h at room temperature, the solvent was removed under reduced 
pressure, and the crude solid was purified by column chromatography (silica gel, 
CH2Cl2/EtOAc 4:6) to give 7.0 g of  i (25 mmol, 90%). 
1H NMR (300 MHz, DMSO) δ 7.03 – 
6.91 (q, J = 6.0, 5.4 Hz, 1H), 4.22 – 4.03 (m, 4H), 3.26 – 3.12 (p, J = 5.4 Hz, 2H), 1.50 – 1.35 
(d, J = 4.1 Hz, 9H). ESI-MS calcd for C9H16BrNO4Na (M+Na
+
), 304.02; found 304.02. 
tetrakis(2-((tert-butoxycarbonyl)amino)ethyl)2,2',2'',2'''-(1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (cyclen NH-Boc) (ii). Cyclen (0.4 g, 
2.3 mmol), sodium carbonate (2.19 g, 20.7 mmol), and bromoacetic acid 2-
tertbutoxycarbonylamino ethyl ester (3.8 g, 13.8 mmol) were suspended in 20 mL of 
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acetonitrile. The reaction mixture was stirred for 72 h at room temperature, and the solvent 
was removed under reduced pressure. The solid residue was purified by column 
chromatography (silica gel, CH3OH/CHCl3 5:95) to afford 1.28 g of cyclen NH-Boc ii (1.3 
mmol, 56%). 
1H NMR (400 MHz, DMSO) δ 6.97 – 6.89 (t, J = 5.8 Hz, 1H), 4.09 – 4.04 (s, 
2H), 3.22 – 3.14 (m, 3H), 1.41 – 1.33 (d, J = 6.8 Hz, 10H). ESI-MS calcd for C44H81BrN8O16 
(M+H
+
), 977.57, and for C44H80BrN8O16Na (M+Na
+
), 999.56; found 977.57 and 999.55. 
tetrakis(2-(3-(4-nitrophenyl)thioureido)ethyl)2,2',2'',2'''-(1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (4). The precursor ii (25 mg, 0.025 
mmol) was dissolved in 1 mL of CH2Cl2, and trifluoroacetic acid (0.19 mL of 50% v/v 
solution in CH2Cl2) was added dropwise. The reaction mixture was stirred for 6 h at room 
temperature, and the solvent and excess of trifluoroacetic acid were removed under reduced 
pressure to afford crude deprotected cyclen  tertrafluoroacetate. Deprotected cyclen was 
reacted without further purification. The crude was dissolved in 1 mL of dry THF and p-
nitrophenyl isothiocynate (48 mg, 0.266 mmol) was added to this solution. After 15 minutes, 
triethylamine was added slowly to bring the pH to 9. Reaction was stirred at room 
temperature for 6 hours and then evaporated to dryness under reduced pressure. The crude 
was purified by column chromatography (silica gel, 2-6% MeOH in CHCl3) to afford 27.5 
mg (0.021mmol, 82%) of receptor 4. 
1H NMR (400 MHz, DMSO) δ 8.27 – 8.10 (m, 8H), 
7.94 – 7.79 (m, 8H), 4.35 – 4.28 (d, J = 8.5 Hz, 8H), 3.83 – 3.78 (s, 8H), 3.22 – 3.13 (dd, J = 
5.2, 1.0 Hz, 4H). ESI-MS calcd for C52H65N16O16S4 (M+H
+
), 1297.36; found 1297.35. 
tetrakis(2-(3-(4-methoxyphenyl)thioureido)ethyl) 2,2',2'',2'''-(1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (5). This compound was synthesized 
from cyclen NH-Boc ii (25 mg, 0.025 mmol) and 4-Methoxyphenyl isothiocyanate (0.041 ml, 
0.297 mmol) in dry THF according to the procedure described for the synthesis of receptor 4. 
The isolated yield of receptor 5 was 12.3 mg (0.01 mmol, 40%). 
1
H NMR (300 MHz, 
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DMSO) δ 7.27 – 7.17 (d, J = 8.4 Hz, 8H), 6.94 – 6.84 (d, J = 8.4 Hz, 8H), 4.27 – 4.20 (s, 8H), 
3.77 – 3.70 (d, J = 0.6 Hz, 12H), 2.56 – 2.40 (d, J = 1.6 Hz, 6H), 2.12 – 2.06 (d, J = 0.6 Hz, 
8H), 1.30 – 1.21 (d, J = 8.7 Hz, 1H). ESI-MS calcd for C56H76N12O12S4Na (M+Na
+
), 
1259.46; found 1259.51. 
tetrakis(2-(3-(4-bromophenyl)thioureido)ethyl)2,2',2'',2'''-(1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (6). This compound was synthesized 
from cyclen NH-Boc ii (25 mg, 0.025 mmol) and 4-Bromophenyl isothiocynate (70 mg, 0.3 
mmol) in isopropyl alcohol according to the procedure described for the synthesis of receptor 
4. The isolated yield of the receptor 6 was 25.2 mg (0.017 mmol, 68.6%). 
1
H NMR (300 
MHz, DMSO) δ 9.92 – 9.76 (s, 4H), 8.06 – 8.00 (s, 4H), 7.60 – 7.30 (m, 15H), 4.32 – 4.21 (d, 
J = 6.0 Hz, 8H), 3.81 – 3.74 (s, 8H), 2.61 – 2.42 (m, 8H). ESI-MS calcd for 
C52H66Br4N12O8S4 (M+H
+
), 1429.06; found 1429.05. 
tetrakis(2-(3-butylthioureido)ethyl)2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetrayl)tetraacetate (7). This compound was synthesized from cyclen NH-Boc ii (25 mg, 
0.025 mmol) and Butyl isothiocynate (0.041 ml, 1.3 mmol) in isopropyl alcohol according to 
the procedure described for the synthesis of receptor 4. The isolated yield of receptor 7 was 
0.0057 mmol, 23%. 
1H NMR (300 MHz, DMSO) δ 9.32 – 9.25 (s, 4H), 8.37 – 8.29, 4.27 – 
4.15 (t, J = 7.5 Hz, 8H), 3.57 – 3.44 (dd, J = 7.8, 7.2 Hz, 8H), 3.43 – 3.27 (m, 11H), 2.19 – 
2.03 (m, 14H), 1.66 – 1.49 (m, 8H), 1.40 – 1.17 (m, 9H), 0.96 – 0.84 (t, J = 7.3 Hz, 13H). 
ESI-MS calcd for C44H85N12O8S4 (M+H
+
), 1037.54; found 1037.35.  
tetrakis(2-benzamidoethyl)2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetrayl)tetraacetate (8). This compound was synthesized from cyclen NH-Boc ii (25 mg, 
0.025 mmol) and Benzoyl chloride (0.046 ml, 0.39 mmol) in isopropyl dichloromethane 
according to the procedure described for the synthesis of receptor 4. The isolated yield of 
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receptor 8 was 0.018 mmol, 74%. 
1
H NMR (400 MHz, CDCl3) δ 7.95 – 7.81 (m, 7H), 7.53 – 
7.32 (m, 12H), 7.29 – 7.16 (d, J = 0.7 Hz, 5H), 4.34 – 4.24 (q, J = 6.3, 5.0 Hz, 6H), 3.71 – 
3.64 (m, 8H), 3.55 – 3.50 (s, 6H), 2.90 – 2.78 (d, J = 9.5 Hz, 13H). ESI-MS calcd for 
C52H65N8O12 (M+H
+
), 993.56; found 993.56. 
Fluorometric titration of HPTS with receptors 4-8. In a typical experiment, an aqueous 
solution (2 mL) containing 50 nM HPTS, 100 mM NaCl, 10 mM NaxH3-xPO4 (x = 1, 2; pH 
6.4) was placed in a thermostated spectrophotometric cell set at 25
0
C. The solution was 
gently stirred during the experiment. Prior to the spectrometric recording, 20μL of 25-5000 
μM solution of receptors 4-8 in DMSO were added to the cell giving the final concentration 
of the receptors in the range of 2.5-500 μM. The emission spectra were then recorded with 
the excitation wavelength of 405 nm. The emission maxima at 510 nm were monitored. 
Binding constant and the maximum emission loss with the confidence interval values were 
then computed using the homemade nonlinear regression curve fitting program. 
Labeling of lactose with APTS dye via reductive amination.  8-Aminopyrene-1,3,6-
trisulfonic acid trisodium salt (APTS) (4.8 mg, 0.009 mmol) and lactose (50.6 mg, 0.140 
mmol, 15 fold excess) were dissolved in 3mL of 15% aqueous acetic acid, sodium 
cyanoborohydide (80 mg, 1.28 mmol, 142 fold excess) was added and reaction was refluxed 
at 70 
o
C for 5 days. The reaction was purified by ion exchange chromatography ( DEAE 
Sephadex A-2S anion exchange resin, 1% HCl eluent). A sample of labeled lactose (3 mg, 
0.0037 mmol) was mixed with sucrose (1.3 mg, 0.0037 mmol, 1 eq) and used in the further 
chemoselective precipitation experiment. 
Labeled lactose 
1
H NMR (300 MHz, D2O) δ 9.14 (s, 1H), 9.11 (d, 1H, J=8.9 Hz), 9.02 (d, 
1H, J=11.9 Hz), 8.92 (d, 1H, J=8.9 Hz), 8.51 (d, 1H, J=8.9 Hz), 8.35 (s, 1H),  4.09-3.63 (m, 
13H). MS (ESI [M]
-
), monosodium salt: 804.27, calcd for C28H31NNaO19S3: 804.06. 
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Labeled lactose + sucrose 
1
H NMR (300 MHz, D2O) δ 9.16 (s, 1H), 9.13 (d, 1H, J=8.9 Hz), 
9.07 (d, 1H, J=11.9 Hz), 8.98 (d, 1H, J=8.9 Hz), 8.51 (d, 1H, J=8.9 Hz), 8.44 (s, 1H), 5.40 (d, 
1H, J=2.9 Hz), 4.20 (d, 1H, J=8.9 Hz), 4.04 (t, 1H, J=8.9 Hz), 3.90-3.15 (m, 23H). 
 
Precipitation of labeled lactose. A solution of lactose-APTS conjugate (1 mM) in 
H2O:MeOH (1:9) was mixed with equal volume of 2 mM solution of cyclen 1 in the same 
solvent system. An immediate precipitate formation was observed. The resulting solution was 
centrifuged for 15 minutes (14,000 rpm). The supernatant was removed, the precipitate was 
suspended in water, and extracted with chloroform. The extraction caused partitioning of 
lactose-APTS conjugate into the aqueous layer and partitioning of cyclen 1 into the organic 
layer. 
Supernatant 
1
H NMR (300 MHZ, D2O) δ 5.40 (d, 1H, J=2.9 Hz), 4.20 (d, 1H, J=8.9 Hz), 
4.04 (t, 1H, J=8.9 Hz), 3.90-3.15 (m, 11H). 
Aqueous layer (after back extraction) 
1
H NMR (300 MHz, D2O) δ 9.10 (s, 1H), 9.05 (d, 1H, 
J=8.9 Hz), 8.92 (d, 1H, J=11.9 Hz), 8.80 (d, 1H, J=8.9 Hz), 8.54 (d, 1H, J=11.9 Hz), 8.42 (s, 
1H), 3.80- 3.50 (m, 12H). 
 
Labeling of lactose with APTS in the presence of sucrose via reductive amination. 
Lactose (1mg, 0.0029 mmol), sucrose (1mg, 0.0029 mmol,) and 8-aminopyrene-1,3,6-
trisulfonic acid trisodium salt (APTS) (4.4 mg, 0.0087 mmol, 3.2 fold excess) were dissolved 
in 2ml of 15% aqueous acetic acid, sodium cyanoborohydide (24 mg, 0.381 mmol, 141 fold 
excess) was added and the reaction mixture was refluxed at 70 
o
C for 2 hours.  Precipitation 
of conjugate was carried out in the same manner as described in the previous section. 
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T=0 hrs  
1
H NMR (300 MHz, D2O) δ 9.01 (s, 1H),  8.97 (d, 1H, J=11.9 Hz), 8.85 (d, 1H, 
J=8.9 Hz), 8.75 (d, 1H, J=11.9 Hz), 8.36 (d, 1H, J=8.9 Hz), 8.16 (s, 1H), 5.29 (s, 1H), 5.11 
(s, 1H), 4.42 (d, 1H, J=8.9 Hz), 4.11 (d, 1H, J=8.9 Hz), 3.94 (t, 1H, J=8.9 Hz), 3.90-3.40 (m, 
23H). 
T=2 hrs  
1
H NMR (300 MHZ, D2O) δ 9.05 (s, 1H), 8.99 (d, 1H, J=8.9 Hz), 8.85 (d, 1H, J=8.9 
Hz), 8.75 (d, 1H, J=11.9 Hz), 8.39 (d, 1H, J=8.9 Hz), 8.12 (s, 1H), 5.35 (d, 1H, J=2.9 Hz), 
4.42 (d, 1H, J=8.9 Hz), 4.18 (d, 1H, J=8.9 Hz), 4.0 (t, 1H, J=8.9 Hz), 3.90-3.40 (m, 23H). 
Supernatant 
1
H NMR (300 MHz, D2O) δ 5.40 (d, 1H, J=2.9 Hz), 4.20 (d, 1H, J=8.9 Hz), 4.03 
(t, 1H, J=8.9 Hz), 3.90-3.40 (m, 11H). 
Lactose 
1
H NMR (300 MHz, D2O) δ 5.19 (d, 1H, J=5.9 Hz), 4.42 (d, 1H, J=5.9 Hz), 3.96-
3.48 (m, 12H). 
Sucrose 
1
H NMR (300 MHz, D2O) δ 5.38 (d, 1H, J=2.9 Hz), 4.19 (d, 1H, J=8.9 Hz), 4.02 (t, 
1H, J=8.9 Hz), 3.90-3.40 (m, 11H) 
 
Labeling of lactose with APTS dye via imine bond. A mixture of lactose (2 mg, 0.0058 
mmol) and APTS (2.7 mg, 0.0114 mmol) was dissolved in the minimum amount of 10% 
aqueous acetic acid (0.2 mL). The reaction mixture was stirred for 12 hrs at 70
0
C. Then the 
reaction mixture was cooled to the room temperature, the solvent was removed under reduced 
pressure, and 
1
H NMR for the solid residue was recorded in D2O. The 
1
H NMR spectrum 
showed some conjugated as well as some free APTS present in the reaction mixture. 
Precipitation of lactose-APTS imine conjugate. The reaction mixture described in the 
previous section was dissolved in 0.2 mL of 80% aqueous methanol. A saturated solution of 
cyclen 1 in 1 mL of the same solvent was prepared. Approximately 10 mg of cyclen 1 was 
dissolved. This saturated solution of cyclen 1 was added to the solution of lactose-APTS 
imine conjugate in small aliquotes. Instantaneous precipitation was observed. The solution of 
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cyclen 1 was added until green fluorescence of reaction mixture disappeared. This precipitate 
was collected by centrifugation. 
Hydrolysis of lactose-APTS imine conjugate. The collected solid was suspended in 10 mL 
of 20% aqueous acetic acid and stirred at 70 
0
C for 12 hours. A gradual dissolvation of 
precipitate was observed during the reaction. Then, the solution was evaporated to dryness 
under reduced pressure and the residual solid was suspended in 10 mL of water. The pH of 
solution was raised to 9 by addition of 1M aqueous ammonia. Then, the solution was 
extracted with chloroform (5 x 25 mL) to remove cyclen 1. The 
1
H NMR spectrum of the 
aqueous layer showed only free APTS dye and free lactose peaks, indicating that hydrolysis 
was successful. 
 
Recovery of unlabeled lactose and APTS dye. The aqueous layer from the previous 
experiment was evaporated and the residue was dissolved in 0.2 mL of 80% aqueous 
methanol. APTS dye was precipitated by application of saturated solution of cyclen 1 in the 
same solvent. The precipitate was removed by centrifugation, and the supernatant was 
evaporated to dryness under reduced pressure. 
1
H NMR analysis of the solid residue revealed 
only peaks consistent with label-free lactose. The remaining precipitate was dissolved in 10 
mL of water, and back extracted with chloroform (5 x 25 mL). This extraction caused 
partitioning of APTS-free cyclen 1 into the organic layer. Both organic and aqueous layers 
were evaporated to dryness, and analyzed by 
1
H NMR. A solid residue from the aqueous 
layer revealed only peaks consistent with APTS, and organic layer revealed only peaks 
consistent with cyclen 1. Overall, 0.4 mg of lactose, 0.9 mg of APTS and 7.2 mg of cyclen 1 
was recovered. 
Synthesis of functionalized cyclen receptor following scheme 4.1 
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Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester i. tert-Butyl-N-(2-hydroxy ethyl) 
carbamate (4.5 g, 28 mmol) was dissolved in dichloromethane (30 mL), and triethylamine 
(3.9 mL, 28 mmol) was added. The mixture was stirred for 10 min at room temperature, and 
bromoacetyl bromide (3.15 mL, 36 mmol) was added dropwise within 5 min. The reaction 
mixture was stirred for 5 h at room temperature, the solvent was removed under reduced 
pressure, and the crude solid was purified by column chromatography (silica gel, 
CH2Cl2/EtOAc 4:6) to give 7.0 g of i (25 mmol, 90%). 
1H NMR (300 MHz, DMSO) δ 7.03 – 
6.91 (q, J = 6.0, 5.4 Hz, 1H), 4.22 – 4.03 (m, 4H), 3.26 – 3.12 (p, J = 5.4 Hz, 2H), 1.50 – 1.35 
(d, J = 4.1 Hz, 9H). ESI-MS calcd for C9H16BrNO4Na (M+Na
+
), 304.01; found 304.02.  
 
tetrakis(2-((tert-butoxycarbonyl)amino)ethyl)2,2',2'',2'''-(2-(4-nitrobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (9). To a solution of p-NO2-Bn-Cyclen 
(40mg, 0.13 mmol) in 10 ml of dry DMF was added Na2CO3 (110mg, 1.04mmol), followed 
by addition of Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester arm i ( 230mg, 1.04 
mmol). The reaction solution was first stirred at 60
0
C for 6hrs followed by overnight stirring 
at room temperature. The solvent was removed under reduced pressure and the crude solid 
was purified by column chromatography (silica gel, 2-6% MeOH in CHCl3) to afford 79.65 
mg (0.072 mmol, 55%) of precursor 9. 
1
H NMR (300 MHz, CDCl3) δ 8.22 – 8.10 (t, J = 9.2 
Hz, 2H), 7.66 – 7.47 (dd, J = 26.7, 8.2 Hz, 2H), 4.39 – 4.04 (s, 8H), 3.58 – 3.43 (s, 10H), 3.40 
– 3.34 (s, 10H), 3.03 – 2.91 (m, 2H), 2.20 – 2.08 (s, 4H), 1.48 – 1.38 (q, J = 3.5 Hz, 38H), 
1.30 – 1.18 (m, 4H). ESI-MS calcd for C51H85N9O18Na (M+Na
+
), 1111.6; found 1134.6. 
 
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-nitrobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (10). The precursor 9 (170 mg, 0.152 
mmol) was dissolved in 5 mL of CH2Cl2, and trifluoroacetic acid (2.4 mL of 50% v/v 
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solution in CH2Cl2) was added dropwise. The reaction mixture was stirred for 6 h at room 
temperature, and the solvent and excess of trifluoroacetic acid were removed under reduced 
pressure to afford crude deprotected cyclen  tertrafluoroacetate. Deprotected cyclen  was 
reacted without further purification. The crude was dissolved in 10 ml of isopropyl alcohol 
and 4-Methoxyphenyl isocynate (182.4 mg, 1.22 mmol) was added to this solution. After 15 
minutes, triethylamine was added slowly to bring the pH to 9. White precipitate produced 
with the addition of triethylamine and acetonitrile was added to dissolve all the solid. 
Reaction was stirred at room temperature for 16 hours and then evaporated to dryness under 
reduced pressure. The crude was purified by column chromatography (silica gel, 2-6% 
MeOH in CHCl3) to afford 79.95 mg (0.061 mmol, 40%) of functionalized OMe receptor 10 . 
1H NMR (400 MHz, DMSO) δ 8.45 – 8.39 (d, J = 3.4 Hz, 4H), 8.21 – 8.15 (d, J = 8.4 Hz, 
1H), 7.65 – 7.55 (d, J = 8.3 Hz, 2H), 7.32 – 7.23 (m, 8H), 6.85 – 6.75 (m, 8H), 6.22 – 6.14 (q, 
J = 5.0 Hz, 4H), 4.15 – 4.00 (q, J = 5.2 Hz, 8H), 3.72 – 3.63 (dd, J = 1.4, 0.8 Hz, 12H), 3.62 – 
3.44 (ddd, J = 29.0, 14.2, 5.5 Hz, 6H), 3.22 – 3.03 (m, 37H), 2.94 – 2.87 (m, 6H). ESI-MS 
calcd for C63H82N13O18 (M+H
+
), 1308.58; found 1308.50. 
 
Alternative scheme for the synthesis of functionalized OMe receptor: 
1-(2-hydroxyethyl)-3-(4-methoxyphenyl)urea (partial arm). To a solution of 4-
Methoxyphenyl isocynate ( 1.0 g, 6.7 mmol) in 15 mL of ethylacetate was added 
ethanolamine (0.404 ml, 6.7 mmol). A white precipitate formed with the addition of 
ethanolamine. The reaction mixture was stirred for two hours at room temperature and then 
evaporated to dryness under reduced pressure to afford (1.365 g, 6.5 mmol) “partial arm” in 
98% yield. 
1
H NMR (300 MHz, DMSO) δ 8.36 – 8.29 (s, 1H), 7.33 – 7.20 (m, 2H), 6.92 – 
6.73 (m, 2H), 6.11 – 6.00 (t, J = 5.5 Hz, 1H), 4.78 – 4.66 (qd, J = 3.8, 2.8, 1.4 Hz, 1H), 3.76 – 
3.63 (m, 3H), 3.51 – 3.25 (m, 2H), 3.23 – 3.05 (dtd, J = 6.7, 5.5, 1.2 Hz, 2H). 13C NMR (75 
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MHz, DMSO) δ 156.33 – 156.07 (s), 154.65 – 154.39 (s), 134.50 – 134.23 (s), 120.08 – 
119.82 (s), 114.69 – 114.42 (s), 61.29 – 61.03 (s), 55.93 – 55.66 (s), 42.63 – 42.37 (s). ESI-
MS calcd for C10H15N2O3 (M+H
+
), 211.1; found 211.15. 
2-(3-(4-methoxyphenyl)ureido)ethyl 2-bromoacetate (complete arm). To the partial arm 
(1.4097 g, 6.7 mmol) dissolved in 100 ml of CH2Cl2 was added triethylamine (1.0311 ml, 
7.39 mmol). The mixture was stirred for 10 min at room temperature, and 
bromoacetyl bromide (1.033 mL, 11.97 mmol) was added dropwise within 5 min. The 
reaction mixture was stirred for 5 h at room temperature, the solvent was removed under 
reduced pressure, and the crude solid was purified by column chromatography (silica gel, 2-
5% MeOH in CHCl3) to give 1.99 g of “complete arm”  (6.02 mmol, 90%). 
1
H NMR (300 
MHz, DMSO) δ 8.39 – 8.33 (s, 1H), 7.34 – 7.17 (m, 2H), 6.87 – 6.73 (m, 2H), 6.21 – 6.10 (t, 
J = 5.9 Hz, 1H), 4.20 – 3.95 (m, 4H), 3.73 – 3.65 (d, J = 0.9 Hz, 3H), 3.40 – 3.22 (m, 2H). 
13C NMR (75 MHz, DMSO) δ 168.01 – 167.75 (s), 156.26 – 155.99 (s), 154.85 – 154.58 (s), 
134.25 – 133.98 (s), 120.39 – 120.13 (s), 114.67 – 114.41 (s), 65.93 – 65.67 (s), 55.91 – 
55.65 (s), 38.88 – 38.61 (s), 28.01 – 27.75 (s). ESI-MS calcd for C12H15BrN2O4Na (M+Na
+
), 
353.02; found 353.05. 
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-nitrobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (10). To a solution of p-NO2-Bn-
Cyclen (40 mg, 0.13 mmol) in 15 ml of dry DMF was added K2CO3 (160 mg, 1.15 mmol). 
The reaction was stirred for 15 min and a solution of complete arm (400 mg,  1.2 mmol) in 10 
ml of dry DMF was added over a period of 30 min. The reaction was then stirred for 6 h at 
room temp. Excess solvent was removed under reduced pressure and crude was purified by 
column chromatography (silica, 2-5% MeOH in CHCl3) to afford 105.6 mg (0.08 mmol, 
62%) of functionalized OMe receptor 10. 
1H NMR (400 MHz, DMSO) δ 8.45 – 8.39 (d, J = 
3.4 Hz, 4H), 8.21 – 8.15 (d, J = 8.4 Hz, 1H), 7.65 – 7.55 (d, J = 8.3 Hz, 2H), 7.32 – 7.23 (m, 
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8H), 6.85 – 6.75 (m, 8H), 6.22 – 6.14 (q, J = 5.0 Hz, 4H), 4.15 – 4.00 (q, J = 5.2 Hz, 8H), 
3.72 – 3.63 (dd, J = 1.4, 0.8 Hz, 12H), 3.62 – 3.44 (ddd, J = 29.0, 14.2, 5.5 Hz, 6H), 3.22 – 
3.03 (m, 37H), 2.94 – 2.87 (m, 6H). 13C NMR (75 MHz, CDCl3) δ 174.45 – 173.69 (m), 
157.25 – 156.88 (d, J = 7.4 Hz), 155.55 – 155.17 (d, J = 8.6 Hz), 147.27 – 147.00 (s), 146.85 
– 146.50 (d, J = 6.0 Hz), 132.69 – 132.12 (dt, J = 12.5, 6.5 Hz), 130.15 – 129.76 (s), 124.27 – 
123.92 (d, J = 6.7 Hz), 121.65 – 120.62 (h, J = 10.2, 7.9 Hz), 114.31 – 113.99 (s), 64.99 – 
64.32 (m), 55.63 – 55.37 (s), 55.10 – 54.58 (m), 52.99 – 52.72 (s),  49.74 – 49.48 (s), 49.15 – 
48.79 (d, J = 7.2 Hz), 48.44 – 48.17 (s), 48.12 – 47.85 (s), 38.76 – 38.50 (s), 32.17 – 31.91 
(s). ESI-MS calcd for C63H82N13O18 (M+H
+
), 1308.58; found 1308.50. 
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-aminobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (11). To the solution of 10 (105 mg, 
0.08 mmol) in 25 ml of dry THF was added Sn (170 mg, 1.44 mmol). The reaction was 
stirred and HCl gas was passed through this solution. The solution became turbid with the 
passage of HCl gas. Continued passing HCl gas and after two h solution became clear. Passed 
HCl gas for another two h and then solvent was removed under reduced pressure to afford a 
colorless, viscous liquid. An ammonical ethyalacetate solution was added to this viscous 
liquid to make pH 10. A white solid was formed with the addition of ammonical ethylacetae, 
which was then centrifuged and solid was separated. Solid was then sonicated with 20 ml of 
10% MeOH in CHCl3 for 15 min. This solution was then centrifuged and clear solution was 
collected. It was then dried under reduced pressure to give a crude solid, which was purified 
by column chromatography (silica, 2-6% MeOH in CHCl3) to afford 64.63 mg (0.051 mmol, 
63%) of reduced functionalize OMe receptor 11. 
1H NMR (300 MHz, DMSO) δ 8.51 – 8.40 
(q, J = 5.1, 4.4 Hz, 4H), 7.36 – 7.21 (m, 8H), 6.90 – 6.74 (t, J = 9.7 Hz, 10H), 6.52 – 6.43 (d, 
J = 7.8 Hz, 2H), 6.32 – 6.21 (m, 4H), 4.33 – 3.91 (m, 8H), 3.71 – 3.51 (m, 16H), 3.50 – 3.37 
(m, 2H), 3.28 – 3.20 (m, 14H), 2.99 – 2.92 (s, 4H), 2.77 – 2.70 (s, 8H). 13C NMR (75 MHz, 
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CDCl3) δ 174.25 – 173.90 (d, J = 6.1 Hz), 157.29 – 157.03 (s), 155.47 – 155.20 (s), 132.74 – 
132.35 (d, J = 9.7 Hz), 121.58 – 120.77 (m), 116.04 – 115.78 (s), 114.29 – 114.03 (s), 64.85 
– 64.39 (d, J = 11.8 Hz), 55.66 – 55.40 (s), 55.10 – 54.80 (m), 50.21 – 49.95 (s), 49.90 – 
49.63 (s), 48.65 – 48.30 (m), 38.76 – 38.50 (s), 32.81 – 29.58 (s). ESI-MS calcd for 
C63H83N13O16Na (M+Na
+
), 1300.61; found 1300.72. 
4-oxo-4-((4-((1,4,7,10-tetrakis(2-(2-(3-(4-methoxyphenyl)ureido)ethoxy)-2-oxoethyl)-
1,4,7,10-tetraazacyclododecan-2-yl)methyl)phenyl)amino)butanoic acid (12). To a 
solution of compound 11 (35 mg, 0.027 mmol) in 6 ml of CH2Cl2 was added succinic 
anhydride (8 mg, 0.08 mmol), followed by an addition of 3 ml of dry THF. The raction was 
stirred at room temperature for 12 h. The reaction mixture was dried under reduced pressure 
and the crude was purified by column chromatography (silica, 10% MeOH in CHCl3) to 
afford 29.74 mg (0.021 mmol, 80%) of compound 12. 
1
H NMR (300 MHz, DMSO) δ 8.51 – 
8.41 (d, J = 6.8 Hz, 4H), 7.54 – 7.45 (m, 2H), 7.36 – 7.20 (m, 8H), 7.18 – 7.06 (t, J = 8.1 Hz, 
2H), 6.84 – 6.72 (m, 8H), 6.30 – 6.21 (d, J = 8.0 Hz, 4H), 4.33 – 3.89 (hept, J = 11.8, 9.7 Hz, 
12H), 3.71 – 3.57 (d, J = 3.2 Hz, 12H), 3.21 – 3.13 (d, J = 5.1 Hz, 8H), 2.98 – 2.86 (m, 2H). 
13
C NMR (75 MHz, CDCl3) δ 155.50 – 155.24 (s), 132.59 – 132.32 (s), 121.35 – 121.09 (s), 
114.31 – 114.05 (s), 68.23 – 67.97 (s), 64.89 – 64.41 (d, J = 15.9 Hz), 55.68 – 55.41 (s), 
50.54 – 50.27 (s), 50.19 – 49.92 (s), 48.53 – 48.27 (s), 38.83 – 38.57 (s). ESI-MS calcd for 
C67H88N13O19 (M+H
+
), 1378.62; found 1378.60. 
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-(4-((3-((tert-
butoxycarbonyl)amino)propyl)amino)-4-oxobutanamido)benzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (13). To a solution of 12 (25 mg, 
0.018 mmol) in 10 ml of dry DMF was added EDC (3.6 mg, 0.024 mmol), followed by 
addition of N-Boc-1,3-propanediamine (4.18 mg, 0.024 mmol). A catalytic amount of DMAP 
was added. Reaction was stirred for 18 h at room temperature, the solvent was removed under 
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reduced pressure to give a crude mixture. This crude mixture was purified by column 
chromatography (silica, 2-6% MeOH in CHCl3) to afford 10.8mg (0.007 mmol, 40%) of 
compound 13. 
1H NMR (400 MHz, DMSO) δ 8.59 – 8.54 (s, 2H), 7.35 – 7.23 (tdd, J = 9.2, 
7.0, 2.4 Hz, 7H), 7.15 – 7.06 (t, J = 6.9 Hz, 1H), 6.99 – 6.91 (t, J = 5.9 Hz, 3H), 6.84 – 6.73 
(tt, J = 5.9, 1.8 Hz, 8H), 6.41 – 6.32 (m, 3H), 4.30 – 3.95 (m, 10H), 3.70 – 3.64 (d, J = 2.8 
Hz, 10H), 3.46 – 3.38 (d, J = 8.2 Hz, 2H), 3.20 – 3.15 (s, 9H), 3.04 – 2.86 (m, 12H), 2.80 – 
2.69 (dd, J = 8.6, 6.5 Hz, 9H), 1.25 – 1.17 (s, 10H). ESI-MS calcd for C75H103N15O20Na 
(M+Na
+
), 1533.75; found 1556.60. 
tert-butyl (3-aminopropyl)carbamate. To a solution of propylenediamine (0.675 ml, 8.1 
mmol) in 40 ml of chloroform, a solution of Boc anhydride (353.3 mg, 1.6 mmol) in 10 ml of 
chloroform was added dropwise over a period of 3hrs. Reaction was stirred for another 3hrs 
at room temperature. Reaction was dried under reduced pressure and crude was purified by 
column chromatography (silica, 4-8% MeOH in CHCl3) to yield 220 mg (1.2 mmol, 78.5%) 
of the product. 
1
H NMR (300 MHz, CDCl3) δ 5.08 – 5.01 (s, 1H), 3.21 – 3.07 (q, J = 8.4, 7.0 
Hz, 2H), 2.78 – 2.61 (q, J = 6.2, 5.8 Hz, 2H), 1.63 – 1.40 (m, 2H), 1.40 – 1.21 (s, 11H). 13C 
NMR (75 MHz, CDCl3) δ 156.49 – 156.22 (s), 79.25 – 78.99 (s), 39.90 – 39.63 (s), 38.66 – 
38.39 (s), 33.63 – 33.37 (s), 28.73 – 28.46 (s). ESI-MS calcd for C8H19N2O2 (M+H
+
), 175.14; 
found 175.20. 
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